<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bull World Health Organ</journal-id><journal-id journal-id-type="iso-abbrev">Bull. World Health Organ</journal-id><journal-id journal-id-type="publisher-id">BLT</journal-id><journal-title-group><journal-title>Bulletin of the World Health Organization</journal-title></journal-title-group><issn pub-type="ppub">0042-9686</issn><issn pub-type="epub">1564-0604</issn><publisher><publisher-name>World Health Organization</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26668434</article-id><article-id pub-id-type="pmc">4669732</article-id><article-id pub-id-type="publisher-id">BLT.15.154161</article-id><article-id pub-id-type="doi">10.2471/BLT.15.154161</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Tuberculosis-associated mortality in Shanghai, China: a longitudinal study</article-title><trans-title-group xml:lang="fr"><trans-title xml:lang="fr">Mortalit&#x000e9; due &#x000e0; la tuberculose &#x000e0; Shanghai, en Chine: une &#x000e9;tude longitudinale</trans-title></trans-title-group><trans-title-group xml:lang="es"><trans-title xml:lang="es">La mortalidad por tuberculosis en Shangh&#x000e1;i, China: un estudio longitudinal</trans-title></trans-title-group><trans-title-group xml:lang="ar"><trans-title xml:lang="ar">&#x00627;&#x00644;&#x00648;&#x00641;&#x00627;&#x00629; &#x00627;&#x00644;&#x00646;&#x00627;&#x0062a;&#x0062c;&#x00629; &#x00639;&#x00646; &#x00645;&#x00631;&#x00636; &#x00627;&#x00644;&#x00633;&#x00644; &#x00641;&#x0064a;&#x000a0;&#x00634;&#x00627;&#x00646;&#x0063a;&#x00647;&#x00627;&#x0064a;&#x000a0;&#x00628;&#x00627;&#x00644;&#x00635;&#x0064a;&#x00646;: &#x0062f;&#x00631;&#x00627;&#x00633;&#x00629;&#x000a0;&#x00637;&#x00648;&#x00644;&#x00627;&#x00646;&#x0064a;&#x00629; </trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title xml:lang="zh">&#x04e2d;&#x056fd;&#x04e0a;&#x06d77;&#x07684;&#x080ba;&#x07ed3;&#x06838;&#x06b7b;&#x04ea1;&#x07387;&#x0ff1a;&#x07eb5;&#x05411;&#x07814;&#x07a76;</trans-title></trans-title-group><trans-title-group xml:lang="ru"><trans-title xml:lang="ru">&#x00414;&#x0043e;&#x0043b;&#x00433;&#x0043e;&#x00441;&#x00440;&#x0043e;&#x00447;&#x0043d;&#x0043e;&#x00435; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00435; &#x00441;&#x0043c;&#x00435;&#x00440;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x0043e;&#x00442; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x00430; &#x00432; &#x00428;&#x00430;&#x0043d;&#x00445;&#x00430;&#x00435;, &#x0041a;&#x00438;&#x00442;&#x00430;&#x00439;</trans-title></trans-title-group><alt-title alt-title-type="author-running-head">Weibing Wang et al.</alt-title><alt-title alt-title-type="title-running-head">Tuberculosis in China</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Weibing</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Qi</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Zhengan</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Yihui</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Yixing</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Liping</given-names></name><xref ref-type="aff" rid="aff5"><sup>e</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hou</surname><given-names>Yun</given-names></name><xref ref-type="aff" rid="aff6"><sup>f</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Yue</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Xu</surname><given-names>Biao</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><aff id="aff1"><label>a</label>Department of Epidemiology, School of Public Health and Key Laboratory of Public Health Safety (Ministry of Education), Fudan University, 138 Yi Xue Yuan Road, Shanghai 200032, <country>China</country>.</aff><aff id="aff2"><label>b</label>Shanghai Center for Disease Control and Prevention, Shanghai, <country>China</country>.</aff><aff id="aff3"><label>c</label>Putuo District Center for Disease Control and Prevention, Shanghai, <country>China</country>.</aff><aff id="aff4"><label>d</label>Pudong District Center for Disease Control and Prevention, Shanghai, <country>China</country>.</aff><aff id="aff5"><label>e</label>Songjiang District Center for Disease Control and Prevention, Shanghai, <country>China</country>.</aff><aff id="aff6"><label>f</label>Yangpu District Center for Disease Control and Prevention, Shanghai, <country>China</country>.</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to Biao Xu (email: <email xlink:href="bxu@shmu.edu.cn">bxu@shmu.edu.cn</email>).</corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>12</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>28</day><month>9</month><year>2015</year></pub-date><volume>93</volume><issue>12</issue><fpage>826</fpage><lpage>833</lpage><history><date date-type="received"><day>16</day><month>2</month><year>2015</year></date><date date-type="rev-recd"><day>18</day><month>7</month><year>2015</year></date><date date-type="accepted"><day>28</day><month>7</month><year>2015</year></date></history><permissions><copyright-statement>(c) 2015 The authors; licensee World Health Organization.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/igo/legalcode">http://creativecommons.org/licenses/by/3.0/igo/legalcode</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.</license-p></license></permissions><abstract><title>Abstract</title><sec><title>Objective</title><p>To determine excess mortality in a cohort of people with tuberculosis in Shanghai.</p></sec><sec><title>Methods</title><p>Participants were local residents in 4 (of 19) districts in Shanghai, registered in one of four tuberculosis clinics between January&#x000a0;1, 2004 and December 31, 2008. Baseline data were collected at the most recent diagnosis of tuberculosis and mortality was assessed between March and May of 2014. We calculated standardized mortality ratios (SMR) and case-fatality rates for all participants and for subgroups. Univariate and multivariate Cox regression models were used to quantify associations between co-morbidities and mortality from all causes and from tuberculosis.</p></sec><sec><title>Findings</title><p>We registered 4569 subjects in the cohort. Overall, the cohort had an SMR for deaths from all causes of 5.2 (95% confidence interval, CI: 4.8&#x02013;5.6). Males had a higher SMR than females (6.1 versus 3.0). After adjustment for age and sex, hazard ratios (HR) for deaths from all causes were significantly greater in previously treated people (HR: 1.26; 95% CI: 1.08&#x02013;1.49) and sputum smear-test positive people (HR: 1.55; 95% CI: 1.35&#x02013;1.78). The risk of death from tuberculosis was also significantly greater for previously treated people (HR: 1.88; 95% CI: 1.24&#x02013;2.86) and smear positive people (HR: 3.16; 95% CI: 2.06&#x02013;4.87).</p></sec><sec><title>Conclusion</title><p>People with tuberculosis in Shanghai have an increased risk of mortality. Earlier diagnosis and more vigilant follow-up may help to reduce mortality in this group.</p></sec></abstract><trans-abstract xml:lang="fr"><title>R&#x000e9;sum&#x000e9;</title><sec><title>Objectif</title><p>D&#x000e9;terminer la surmortalit&#x000e9; dans une cohorte de personnes atteintes de tuberculose &#x000e0; Shanghai.</p></sec><sec><title>M&#x000e9;thodes</title><p>Les participants &#x000e9;taient des habitants de 4&#x000a0;districts (sur&#x000a0;19) de Shanghai, enregistr&#x000e9;s dans une des quatre cliniques de la tuberculose entre le 1er&#x000a0;janvier&#x000a0;2004 et le 31&#x000a0;d&#x000e9;cembre&#x000a0;2008. Des donn&#x000e9;es de r&#x000e9;f&#x000e9;rence ont &#x000e9;t&#x000e9; recueillies lors du diagnostic le plus r&#x000e9;cent de tuberculose et la mortalit&#x000e9; a &#x000e9;t&#x000e9; &#x000e9;valu&#x000e9;e entre mars et mai&#x000a0;2014. Nous avons calcul&#x000e9; les rapports standardis&#x000e9;s de mortalit&#x000e9; (RSM) et les taux de l&#x000e9;talit&#x000e9; pour tous les participants ainsi que pour des sous-groupes. Des mod&#x000e8;les de r&#x000e9;gression univari&#x000e9;e et multivari&#x000e9;e de Cox ont &#x000e9;t&#x000e9; utilis&#x000e9;s pour quantifier les associations entre les comorbidit&#x000e9;s et la mortalit&#x000e9;, toutes causes confondues et due &#x000e0; la tuberculose.</p></sec><sec><title>R&#x000e9;sultats</title><p>Nous avons enregistr&#x000e9; 4569&#x000a0;sujets dans la cohorte. Globalement, la cohorte avait un RSM pour les d&#x000e9;c&#x000e8;s toutes causes confondues de 5,2 (intervalle de confiance (IC) de 95%: 4,8-5,6). Les hommes affichaient un RSM plus &#x000e9;lev&#x000e9; que les femmes (6,1 contre 3,0). Apr&#x000e8;s ajustement en fonction de l'&#x000e2;ge et du sexe, les ratios de risque (RR) de d&#x000e9;c&#x000e8;s toutes causes confondues &#x000e9;taient nettement plus &#x000e9;lev&#x000e9;s chez les personnes ayant pr&#x000e9;c&#x000e9;demment re&#x000e7;u un traitement (RR: 1,26; IC 95%: 1,08&#x02013;1,49) et les personnes &#x000e0; frottis d'expectoration positif (RR: 1,55; IC 95%: 1,35-1,78). Le risque de d&#x000e9;c&#x000e8;s d&#x000fb; &#x000e0; la tuberculose &#x000e9;tait &#x000e9;galement beaucoup plus important pour les personnes ayant pr&#x000e9;c&#x000e9;demment re&#x000e7;u un traitement (RR: 1,88; IC 95%: 1,24-2,86) et les personnes &#x000e0; frottis positif (RR: 3,16; IC 95%: 2,06-4,87).</p></sec><sec><title>Conclusion</title><p>Les personnes atteintes de tuberculose &#x000e0; Shanghai pr&#x000e9;sentent un risque accru de mortalit&#x000e9;. Un diagnostic plus pr&#x000e9;coce et un suivi plus attentif pourraient permettre de r&#x000e9;duire la mortalit&#x000e9; dans ce groupe.</p></sec></trans-abstract><trans-abstract xml:lang="es"><title>Resumen</title><sec><title>Objetivo</title><p>Determinar el exceso de mortalidad en una cohorte de personas con tuberculosis en Shangh&#x000e1;i.<bold/></p></sec><sec><title>M&#x000e9;todos</title><p>Los participantes eran residentes locales de 4 (de 19) distritos de Shangh&#x000e1;i, registrados en uno de los cuatro consultorios antituberculosos entre el 1 de enero de 2004 y el 31 de diciembre de 2008. Se recogieron datos de referencia de los diagn&#x000f3;sticos de tuberculosis m&#x000e1;s recientes y se evalu&#x000f3; la mortalidad entre marzo y mayo de 2014. Se calcularon las tasas de mortalidad estandarizadas (SMR) y la tasa de letalidad de todos los participantes y por subgrupos. Se utilizaron modelos de regresi&#x000f3;n de Cox univariables y multivariables para cuantificar las asociaciones entre la comorbilidad y la mortalidad de todas las causas de tuberculosis.</p></sec><sec><title>Resultados</title><p>Se registraron 4.569 sujetos en la cohorte. En general, la cohorte ten&#x000ed;a una SMR para muertes de todas las causas de 5,2 (intervalo de confianza del 95%, IC: 4,8&#x02013;5,6). Los hombres ten&#x000ed;an una SMR mayor que las mujeres (6,1 frente a 3,0). Tras ajustarlos de acuerdo a edad y sexo, los cocientes de riesgo (HR) para las muertes de todas las causas eran significantemente mayores en personas tratadas con anterioridad (HR: 1,26 (IC del 95%: 1,08&#x02013;1,49) y personas con pruebas de esputo positivas (HR: 1,55 (IC del 95%: 1,35&#x02013;1,78). El riesgo de muerte por tuberculosis tambi&#x000e9;n era significativamente mayor en personas tratadas con anterioridad (HR: 1,88 (IC del 95%: 1,24-2,86) y personas con pruebas de esputo positivas (HR: 3,16 (IC del 95%: 2,06&#x02013;4,87).</p></sec><sec><title>Conclusi&#x000f3;n</title><p>Las personas con tuberculosis en Shangh&#x000e1;i tienen un mayor riesgo de mortalidad. Unos diagn&#x000f3;sticos m&#x000e1;s tempranos y un seguimiento m&#x000e1;s atento podr&#x000ed;an ayudar a reducir la mortalidad de este grupo.</p></sec></trans-abstract><trans-abstract xml:lang="ar"><title>&#x00645;&#x00644;&#x0062e;&#x00635; </title><sec><title>&#x00627;&#x00644;&#x0063a;&#x00631;&#x00636; </title><p>&#x0062a;&#x0062d;&#x0062f;&#x0064a;&#x0062f; &#x00627;&#x00644;&#x00632;&#x0064a;&#x00627;&#x0062f;&#x00629; &#x00641;&#x0064a; &#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00648;&#x00641;&#x00627;&#x00629; &#x00641;&#x0064a; &#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00645;&#x00646; &#x00627;&#x00644;&#x00645;&#x00635;&#x00627;&#x00628;&#x0064a;&#x00646; &#x00628;&#x00627;&#x00644;&#x00633;&#x00644; &#x00641;&#x0064a; &#x00634;&#x00627;&#x00646;&#x0063a;&#x00647;&#x00627;&#x0064a;. </p></sec><sec><title>&#x00627;&#x00644;&#x00637;&#x00631;&#x0064a;&#x00642;&#x00629; </title><p>&#x00643;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x00634;&#x00627;&#x00631;&#x00643;&#x00648;&#x00646; &#x00645;&#x00646; &#x00627;&#x00644;&#x00633;&#x00643;&#x00627;&#x00646; &#x00627;&#x00644;&#x00645;&#x0062d;&#x00644;&#x0064a;&#x0064a;&#x00646; &#x00641;&#x0064a; 4&#x000a0;&#x00623;&#x0062d;&#x0064a;&#x00627;&#x00621; (&#x00645;&#x00646; &#x00628;&#x0064a;&#x00646; 19&#x000a0;&#x0062d;&#x0064a;&#x0064b;&#x00627;) &#x00641;&#x0064a; &#x00634;&#x00646;&#x0063a;&#x00647;&#x00627;&#x0064a;&#x0060c; &#x00648;&#x00642;&#x0062f; &#x0062a;&#x00645; &#x0062a;&#x00633;&#x0062c;&#x0064a;&#x00644;&#x00647;&#x00645; &#x00641;&#x0064a; &#x00648;&#x00627;&#x0062d;&#x0062f;&#x00629; &#x00645;&#x00646; &#x00623;&#x00631;&#x00628;&#x00639; &#x00639;&#x0064a;&#x00627;&#x0062f;&#x00627;&#x0062a; &#x00644;&#x00639;&#x00644;&#x00627;&#x0062c; &#x00627;&#x00644;&#x00633;&#x00644; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00641;&#x0062a;&#x00631;&#x00629; &#x00628;&#x0064a;&#x00646; 1&#x000a0;&#x0064a;&#x00646;&#x00627;&#x0064a;&#x00631;/&#x00643;&#x00627;&#x00646;&#x00648;&#x00646; &#x00627;&#x00644;&#x0062b;&#x00627;&#x00646;&#x0064a; 2004 &#x00648;31&#x000a0;&#x0062f;&#x0064a;&#x00633;&#x00645;&#x00628;&#x00631;/&#x00643;&#x00627;&#x00646;&#x00648;&#x00646; &#x00627;&#x00644;&#x00623;&#x00648;&#x00644; 2008. &#x00648;&#x00642;&#x0062f; &#x0062a;&#x00645; &#x0062c;&#x00645;&#x00639; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00627;&#x00646;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00623;&#x00633;&#x00627;&#x00633;&#x0064a;&#x00629; &#x00639;&#x00644;&#x00649; &#x00645;&#x00633;&#x0062a;&#x00648;&#x00649; &#x00623;&#x0062d;&#x0062f;&#x0062b; &#x00627;&#x00644;&#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x00645; &#x0062a;&#x00634;&#x0062e;&#x0064a;&#x00635;&#x00647;&#x00627; &#x00643;&#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00625;&#x00635;&#x00627;&#x00628;&#x00629; &#x00628;&#x00627;&#x00644;&#x00633;&#x00644;&#x0060c; &#x00643;&#x00645;&#x00627; &#x0062a;&#x00645; &#x0062a;&#x00642;&#x0062f;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00648;&#x00641;&#x0064a;&#x00627;&#x0062a; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00641;&#x0062a;&#x00631;&#x00629; &#x00628;&#x0064a;&#x00646; &#x00634;&#x00647;&#x00631;&#x0064a; &#x00645;&#x00627;&#x00631;&#x00633;/&#x00622;&#x00630;&#x00627;&#x00631; &#x00648;&#x00645;&#x00627;&#x0064a;&#x00648;/&#x00623;&#x0064a;&#x00627;&#x00631;&#x000a0;2014. &#x00648;&#x0062d;&#x00633;&#x00628;&#x00646;&#x00627; &#x00646;&#x00633;&#x00628; &#x00627;&#x00644;&#x00648;&#x00641;&#x0064a;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00642;&#x0064a;&#x00627;&#x00633;&#x0064a;&#x00629; (SMR) &#x00648;&#x00645;&#x00639;&#x0062f;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00648;&#x00641;&#x0064a;&#x00627;&#x0062a; &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00635;&#x00627;&#x00628;&#x00629; &#x00628;&#x00627;&#x00644;&#x00646;&#x00638;&#x00631; &#x00625;&#x00644;&#x00649; &#x0062c;&#x00645;&#x0064a;&#x00639; &#x00627;&#x00644;&#x00645;&#x00634;&#x00627;&#x00631;&#x00643;&#x0064a;&#x00646; &#x00648;&#x00627;&#x00644;&#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00641;&#x00631;&#x00639;&#x0064a;&#x00629;. <bold/>&#x00648;&#x0062a;&#x00645; &#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x00646;&#x00645;&#x00627;&#x00630;&#x0062c; &#x00627;&#x00646;&#x0062d;&#x0062f;&#x00627;&#x00631; &#x00643;&#x00648;&#x00643;&#x00633; &#x00630;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x0062a;&#x0063a;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00623;&#x0062d;&#x00627;&#x0062f;&#x0064a; &#x00648;&#x00627;&#x00644;&#x00645;&#x0062a;&#x00639;&#x0062f;&#x0062f;&#x00629; &#x00627;&#x00644;&#x00645;&#x0062a;&#x0063a;&#x0064a;&#x00631;&#x00627;&#x0062a; &#x00644;&#x00642;&#x0064a;&#x00627;&#x00633; &#x00645;&#x0062f;&#x00649; &#x00627;&#x00644;&#x00627;&#x00631;&#x0062a;&#x00628;&#x00627;&#x00637; &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00625;&#x00635;&#x00627;&#x00628;&#x00629; &#x00628;&#x00623;&#x00643;&#x0062b;&#x00631; &#x00645;&#x00646; &#x00645;&#x00631;&#x00636; &#x00641;&#x0064a; &#x00646;&#x00641;&#x00633; &#x00627;&#x00644;&#x00648;&#x00642;&#x0062a; &#x00648;&#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00648;&#x00641;&#x00627;&#x00629; &#x00627;&#x00644;&#x00646;&#x00627;&#x0062a;&#x0062c;&#x00629; &#x00639;&#x00646; &#x0062c;&#x00645;&#x0064a;&#x00639; &#x00627;&#x00644;&#x00623;&#x00633;&#x00628;&#x00627;&#x00628; &#x00648;&#x00627;&#x00644;&#x00646;&#x00627;&#x0062a;&#x0062c;&#x00629; &#x00639;&#x00646; &#x00645;&#x00631;&#x00636; &#x00627;&#x00644;&#x00633;&#x00644;. </p></sec><sec><title>&#x00627;&#x00644;&#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; </title><p>&#x00633;&#x0062c;&#x00644;&#x00646;&#x00627; 4569&#x000a0;&#x00645;&#x00646; &#x00627;&#x00644;&#x0062d;&#x00627;&#x00644;&#x00627;&#x0062a; &#x00645;&#x0062d;&#x00644; &#x00627;&#x00644;&#x0062f;&#x00631;&#x00627;&#x00633;&#x00629; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00627;&#x00644;&#x00645;&#x00634;&#x00627;&#x00631; &#x00625;&#x00644;&#x0064a;&#x00647;&#x00627;. <bold/>&#x00648;&#x00628;&#x00648;&#x0062c;&#x00647; &#x00639;&#x00627;&#x00645;&#x0060c; &#x00628;&#x00644;&#x0063a;&#x0062a; &#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00648;&#x00641;&#x0064a;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00642;&#x0064a;&#x00627;&#x00633;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00646;&#x00627;&#x0062a;&#x0062c;&#x00629; &#x00639;&#x00646; &#x0062c;&#x00645;&#x0064a;&#x00639; &#x00627;&#x00644;&#x00623;&#x00633;&#x00628;&#x00627;&#x00628; &#x00641;&#x0064a; &#x00647;&#x00630;&#x00647; &#x00627;&#x00644;&#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; 5.2 (&#x00628;&#x00646;&#x00633;&#x00628;&#x00629; &#x00623;&#x00631;&#x0062c;&#x0062d;&#x0064a;&#x00629; &#x00645;&#x00642;&#x0062f;&#x00627;&#x00631;&#x00647;&#x00627; <styled-content style-type="direction" style="direction:ltr;">&#x0200f;&#x0200f;95%:&#x000a0;4.8&#x02013;5.6)</styled-content>. &#x00648;&#x00627;&#x00631;&#x0062a;&#x00641;&#x00639;&#x0062a; &#x00646;&#x00633;&#x00628;&#x00629; &#x00627;&#x00644;&#x00648;&#x00641;&#x0064a;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00642;&#x0064a;&#x00627;&#x00633;&#x0064a;&#x00629; &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00631;&#x0062c;&#x00627;&#x00644; &#x00645;&#x00642;&#x00627;&#x00631;&#x00646;&#x00629;&#x0064b; &#x00628;&#x00627;&#x00644;&#x00646;&#x00633;&#x00627;&#x00621; (6.1 &#x00645;&#x00642;&#x00627;&#x00628;&#x00644; 3.0). <bold/>&#x00648;&#x00628;&#x00639;&#x0062f; &#x0062a;&#x00639;&#x0062f;&#x0064a;&#x00644; &#x00639;&#x00627;&#x00645;&#x00644; &#x00627;&#x00644;&#x00639;&#x00645;&#x00631; &#x00648;&#x00627;&#x00644;&#x0062c;&#x00646;&#x00633;&#x0060c; &#x00643;&#x00627;&#x00646;&#x0062a; &#x00646;&#x00633;&#x00628; &#x0062e;&#x00637;&#x00648;&#x00631;&#x00629; (HR) &#x00627;&#x00644;&#x0062a;&#x00639;&#x00631;&#x00636; &#x00644;&#x00644;&#x00648;&#x00641;&#x00627;&#x00629; &#x00627;&#x00644;&#x00646;&#x00627;&#x0062a;&#x0062c;&#x00629; &#x00639;&#x00646; &#x0062c;&#x00645;&#x0064a;&#x00639; &#x00627;&#x00644;&#x00623;&#x00633;&#x00628;&#x00627;&#x00628; &#x00623;&#x00643;&#x0062b;&#x00631; &#x00627;&#x00631;&#x0062a;&#x00641;&#x00627;&#x00639;&#x0064b;&#x00627; &#x00628;&#x00634;&#x00643;&#x00644; &#x00645;&#x00644;&#x0062d;&#x00648;&#x00638; &#x00644;&#x0062f;&#x00649; &#x00627;&#x00644;&#x00623;&#x00634;&#x0062e;&#x00627;&#x00635; &#x00627;&#x00644;&#x00630;&#x0064a;&#x00646; &#x00633;&#x00628;&#x00642;&#x0062a; &#x00645;&#x00639;&#x00627;&#x00644;&#x0062c;&#x0062a;&#x00647;&#x00645; (&#x00646;&#x00633;&#x00628;&#x00629; &#x0062e;&#x00637;&#x00648;&#x00631;&#x00629;: 1.26&#x0061b; &#x00628;&#x00646;&#x00633;&#x00628;&#x00629; &#x00623;&#x00631;&#x0062c;&#x0062d;&#x0064a;&#x00629; &#x00645;&#x00642;&#x0062f;&#x00627;&#x00631;&#x00647;&#x00627; <styled-content style-type="direction" style="direction:ltr;">&#x0200f;95%:&#x000a0;1.08&#x02013; </styled-content>1.49) &#x00648;&#x00644;&#x0062f;&#x00649; &#x00627;&#x00644;&#x00623;&#x00634;&#x0062e;&#x00627;&#x00635; &#x00627;&#x00644;&#x00630;&#x0064a;&#x00646; &#x00643;&#x00627;&#x00646;&#x0062a; &#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; &#x00627;&#x0062e;&#x0062a;&#x00628;&#x00627;&#x00631; &#x00645;&#x00633;&#x0062d;&#x00629; &#x00627;&#x00644;&#x00628;&#x00644;&#x0063a;&#x00645; &#x00627;&#x00644;&#x0062e;&#x00627;&#x00635;&#x00629; &#x00628;&#x00647;&#x00645; &#x00625;&#x0064a;&#x0062c;&#x00627;&#x00628;&#x0064a;&#x00629; (HR: 1.55&#x0061b; &#x00628;&#x00646;&#x00633;&#x00628;&#x00629; &#x00623;&#x00631;&#x0062c;&#x0062d;&#x0064a;&#x00629; &#x00645;&#x00642;&#x0062f;&#x00627;&#x00631;&#x00647;&#x00627; <styled-content style-type="direction" style="direction:ltr;">&#x0200f;95%:&#x000a0;1.35&#x02013;1.78)</styled-content>. &#x00648;&#x00643;&#x00627;&#x00646; &#x0062e;&#x00637;&#x00631; &#x00627;&#x00644;&#x00648;&#x00641;&#x00627;&#x00629; &#x00627;&#x00644;&#x00646;&#x00627;&#x0062a;&#x0062c;&#x00629; &#x00639;&#x00646; &#x00627;&#x00644;&#x00633;&#x00644; &#x00623;&#x00643;&#x0062b;&#x00631; &#x00627;&#x00631;&#x0062a;&#x00641;&#x00627;&#x00639;&#x0064b;&#x00627; &#x00623;&#x0064a;&#x00636;&#x0064b;&#x00627; &#x00628;&#x00634;&#x00643;&#x00644; &#x00645;&#x00644;&#x0062d;&#x00648;&#x00638; &#x00644;&#x0062f;&#x00649; &#x00627;&#x00644;&#x00623;&#x00634;&#x0062e;&#x00627;&#x00635; &#x00627;&#x00644;&#x00630;&#x0064a;&#x00646; &#x00633;&#x00628;&#x00642;&#x0062a; &#x00645;&#x00639;&#x00627;&#x00644;&#x0062c;&#x0062a;&#x00647;&#x00645; (&#x00646;&#x00633;&#x00628;&#x00629; &#x0062e;&#x00637;&#x00648;&#x00631;&#x00629;: 1.88&#x0061b; &#x00628;&#x00646;&#x00633;&#x00628;&#x00629; &#x00623;&#x00631;&#x0062c;&#x0062d;&#x0064a;&#x00629; &#x00645;&#x00642;&#x0062f;&#x00627;&#x00631;&#x00647;&#x00627; <styled-content style-type="direction" style="direction:ltr;">95&#x0200f;%:&#x000a0;1.24&#x02013; </styled-content>2.86) &#x00648;&#x00644;&#x0062f;&#x00649; &#x00627;&#x00644;&#x00623;&#x00634;&#x0062e;&#x00627;&#x00635; &#x00627;&#x00644;&#x00630;&#x0064a;&#x00646; &#x00643;&#x00627;&#x00646;&#x0062a; &#x00646;&#x0062a;&#x00627;&#x00626;&#x0062c; &#x00627;&#x00644;&#x00645;&#x00633;&#x0062d;&#x00629; &#x00627;&#x00644;&#x0062e;&#x00627;&#x00635;&#x00629; &#x00628;&#x00647;&#x00645; &#x00625;&#x0064a;&#x0062c;&#x00627;&#x00628;&#x0064a;&#x00629; (&#x00646;&#x00633;&#x00628;&#x00629; &#x0062e;&#x00637;&#x00648;&#x00631;&#x00629;:&#x000a0;3.16&#x0061b; &#x00628;&#x00646;&#x00633;&#x00628;&#x00629; &#x00623;&#x00631;&#x0062c;&#x0062d;&#x0064a;&#x00629; &#x00645;&#x00642;&#x0062f;&#x00627;&#x00631;&#x00647;&#x00627; <styled-content style-type="direction" style="direction:ltr;">&#x0200f;95%:&#x000a0;2.06&#x02013;4.87</styled-content>) <bold>. </bold></p></sec><sec><title>&#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00646;&#x0062a;&#x00627;&#x0062c; </title><p>&#x0064a;&#x00639;&#x00627;&#x00646;&#x0064a; &#x00627;&#x00644;&#x00645;&#x00635;&#x00627;&#x00628;&#x00648;&#x00646; &#x00628;&#x00627;&#x00644;&#x00633;&#x00644; &#x00641;&#x0064a; &#x00634;&#x00627;&#x00646;&#x0063a;&#x00647;&#x00627;&#x0064a; &#x00645;&#x00646; &#x00632;&#x0064a;&#x00627;&#x0062f;&#x00629; &#x0062e;&#x00637;&#x00631; &#x00627;&#x00644;&#x0062a;&#x00639;&#x00631;&#x00636; &#x00644;&#x00644;&#x00648;&#x00641;&#x00627;&#x00629;. &#x00648;&#x00642;&#x0062f; &#x0064a;&#x00633;&#x00627;&#x00639;&#x0062f; &#x00627;&#x00644;&#x0062a;&#x00634;&#x0062e;&#x0064a;&#x00635; &#x00627;&#x00644;&#x00645;&#x00628;&#x00643;&#x00631; &#x00644;&#x00644;&#x00645;&#x00631;&#x00636; &#x00648;&#x00627;&#x00644;&#x00645;&#x00632;&#x0064a;&#x0062f; &#x00645;&#x00646; &#x00627;&#x00644;&#x00645;&#x0062a;&#x00627;&#x00628;&#x00639;&#x00629; &#x00627;&#x00644;&#x00637;&#x00628;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062f;&#x00642;&#x0064a;&#x00642;&#x00629; &#x00641;&#x0064a; &#x0062a;&#x00642;&#x00644;&#x0064a;&#x00644; &#x00645;&#x00639;&#x0062f;&#x00644; &#x00627;&#x00644;&#x00648;&#x00641;&#x0064a;&#x00627;&#x0062a; &#x00641;&#x0064a; &#x00647;&#x00630;&#x00647; &#x00627;&#x00644;&#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629;. </p></sec></trans-abstract><trans-abstract xml:lang="zh"><title>&#x06458;&#x08981;</title><sec><title>&#x076ee;&#x07684;</title><p>&#x065e8;&#x05728;&#x0786e;&#x05b9a;&#x04e0a;&#x06d77;&#x05730;&#x0533a;&#x080ba;&#x07ed3;&#x06838;&#x075c5;&#x060a3;&#x08005;&#x07684;&#x08d85;&#x0989d;&#x06b7b;&#x04ea1;&#x07387;&#x03002;</p></sec><sec><title>&#x065b9;&#x06cd5;</title><p>&#x053c2;&#x04e0e;&#x08005;&#x0662f;&#x066fe;&#x04e8e;2004&#x000a0;&#x05e74;&#x000a0;1&#x000a0;&#x06708;&#x000a0;1&#x000a0;&#x065e5;&#x081f3;&#x000a0;2008&#x000a0;&#x05e74;&#x000a0;12&#x000a0;&#x06708;&#x000a0;31&#x000a0;&#x065e5;&#x05728;&#x056db;&#x05bb6;&#x080ba;&#x07ed3;&#x06838;&#x075c5;&#x08bca;&#x06240;&#x05176;&#x04e2d;&#x04e00;&#x05bb6;&#x0767b;&#x08bb0;&#x08fc7;&#x07684;&#x03001;&#x04e0a;&#x06d77;&#x05e02;&#x000a0;4&#x000a0;&#x04e2a;&#x0533a;&#x0ff08;&#x05171;&#x000a0;19&#x000a0;&#x04e2a;&#x0533a;&#x0ff09;&#x07684;&#x05f53;&#x05730;&#x05c45;&#x06c11;&#x03002;&#x06211;&#x04eec;&#x06536;&#x096c6;&#x04e86;&#x06700;&#x08fd1;&#x07684;&#x080ba;&#x07ed3;&#x06838;&#x075c5;&#x08bca;&#x065ad;&#x07684;&#x057fa;&#x07ebf;&#x06570;&#x0636e;&#x0ff0c;&#x05e76;&#x05bf9;&#x000a0;2014&#x000a0;&#x05e74;&#x000a0;3&#x000a0;&#x06708;&#x081f3;&#x000a0;5&#x000a0;&#x06708;&#x07684;&#x06b7b;&#x04ea1;&#x07387;&#x08fdb;&#x0884c;&#x04e86;&#x08bc4;&#x04f30;&#x03002;&#x06211;&#x04eec;&#x08ba1;&#x07b97;&#x051fa;&#x06240;&#x06709;&#x053c2;&#x04e0e;&#x08005;&#x0548c;&#x05b50;&#x07ec4;&#x07684;&#x06807;&#x051c6;&#x05316;&#x06b7b;&#x04ea1;&#x07387;&#x0548c;&#x075c5;&#x06b7b;&#x07387;&#x0ff0c;&#x05e76;&#x091c7;&#x07528;&#x05355;&#x053d8;&#x091cf;&#x0548c;&#x0591a;&#x053d8;&#x091cf;&#x000a0;Cox&#x000a0;&#x056de;&#x05f52;&#x06a21;&#x0578b;&#x091cf;&#x05316;&#x05404;&#x079cd;&#x0539f;&#x056e0;&#x04e0e;&#x080ba;&#x07ed3;&#x06838;&#x05bfc;&#x081f4;&#x07684;&#x05171;&#x075c5;&#x075c7;&#x04e0e;&#x06b7b;&#x04ea1;&#x07387;&#x04e4b;&#x095f4;&#x07684;&#x05173;&#x08054;&#x03002;</p></sec><sec><title>&#x07ed3;&#x0679c;</title><p>&#x06211;&#x04eec;&#x0767b;&#x08bb0;&#x04e86;&#x075c5;&#x060a3;&#x04e2d;&#x000a0;4569&#x000a0;&#x0540d;&#x053d7;&#x08bd5;&#x08005;&#x03002;&#x0603b;&#x04f53;&#x0800c;&#x08a00;&#x0ff0c;&#x05404;&#x079cd;&#x0539f;&#x056e0;&#x05bfc;&#x081f4;&#x07684;&#x06b7b;&#x04ea1;&#x060a3;&#x08005;&#x07684;&#x06807;&#x051c6;&#x05316;&#x06b7b;&#x04ea1;&#x07387;&#x04e3a;&#x000a0;5.2&#x000a0;&#x0ff08;95%&#x000a0;&#x07f6e;&#x04fe1;&#x0533a;&#x095f4;&#x0ff1a;4.8&#x02013;5.6&#x0ff09;&#x03002;&#x07537;&#x06027;&#x07684;&#x06807;&#x051c6;&#x05316;&#x06b7b;&#x04ea1;&#x07387;&#x09ad8;&#x04e8e;&#x05973;&#x06027;&#x000a0;(6.1&#x000a0;&#x06bd4;&#x000a0;3.0)&#x03002;&#x08c03;&#x06574;&#x05e74;&#x09f84;&#x0548c;&#x06027;&#x0522b;&#x0540e;&#x0ff0c;&#x04ee5;&#x0524d;&#x063a5;&#x053d7;&#x08fc7;&#x06cbb;&#x07597;&#x07684;&#x060a3;&#x08005;&#x0ff08;&#x098ce;&#x09669;&#x06bd4;&#x0ff1a;1.26&#x0ff0c;95%&#x000a0;&#x07f6e;&#x04fe1;&#x0533a;&#x095f4;&#x0ff1a;1.08-1.49&#x0ff09;&#x0548c;&#x075f0;&#x06d82;&#x07247;&#x08bd5;&#x09a8c;&#x05448;&#x09633;&#x06027;&#x07684;&#x060a3;&#x08005;&#x0ff08;&#x098ce;&#x09669;&#x06bd4;&#x0ff1a;1.55&#x0ff0c;95%&#x000a0;&#x07f6e;&#x04fe1;&#x0533a;&#x095f4;&#x0ff1a;1.35-1.78&#x0ff09;&#x04e2d;&#x05404;&#x079cd;&#x0539f;&#x056e0;&#x05bfc;&#x081f4;&#x07684;&#x06b7b;&#x04ea1;&#x098ce;&#x09669;&#x06bd4;&#x0660e;&#x0663e;&#x066f4;&#x09ad8;&#x03002;&#x04ee5;&#x0524d;&#x063a5;&#x053d7;&#x08fc7;&#x06cbb;&#x07597;&#x07684;&#x060a3;&#x08005;&#x0ff08;&#x098ce;&#x09669;&#x06bd4;&#x07387;&#x0ff1a;1.88&#x0ff0c;95%&#x000a0;&#x07f6e;&#x04fe1;&#x0533a;&#x095f4;&#x0ff1a;1.24-2.86&#x0ff09;&#x0548c;&#x075f0;&#x06d82;&#x07247;&#x08bd5;&#x09a8c;&#x05448;&#x09633;&#x06027;&#x07684;&#x060a3;&#x08005;&#x0ff08;&#x098ce;&#x09669;&#x06bd4;&#x07387;&#x0ff1a;3.16&#x0ff0c;95%&#x000a0;&#x07f6e;&#x04fe1;&#x0533a;&#x095f4;&#x0ff1a;2.06-4.87&#x0ff09;&#x04e2d;&#x080ba;&#x07ed3;&#x06838;&#x05bfc;&#x081f4;&#x07684;&#x06b7b;&#x04ea1;&#x098ce;&#x09669;&#x04e5f;&#x0660e;&#x0663e;&#x066f4;&#x09ad8;&#x03002;</p></sec><sec><title>&#x07ed3;&#x08bba;</title><p>&#x04e0a;&#x06d77;&#x05730;&#x0533a;&#x080ba;&#x07ed3;&#x06838;&#x075c5;&#x060a3;&#x08005;&#x07684;&#x06b7b;&#x04ea1;&#x07387;&#x098ce;&#x09669;&#x0589e;&#x052a0;&#x03002;&#x053ca;&#x065e9;&#x07684;&#x08bca;&#x065ad;&#x0548c;&#x066f4;&#x052a0;&#x08b66;&#x089c9;&#x07684;&#x0968f;&#x08bbf;&#x08bca;&#x067e5;&#x053ef;&#x080fd;&#x06709;&#x052a9;&#x04e8e;&#x0964d;&#x04f4e;&#x080ba;&#x07ed3;&#x06838;&#x060a3;&#x08005;&#x07684;&#x06b7b;&#x04ea1;&#x07387;&#x03002;</p></sec></trans-abstract><trans-abstract xml:lang="ru"><title>&#x00420;&#x00435;&#x00437;&#x0044e;&#x0043c;&#x00435;</title><sec><title>&#x00426;&#x00435;&#x0043b;&#x0044c;</title><p>&#x0041e;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x00435; &#x0043f;&#x0043e;&#x00432;&#x0044b;&#x00448;&#x00435;&#x0043d;&#x0043d;&#x0043e;&#x00439; &#x00441;&#x0043c;&#x00435;&#x00440;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00432; &#x0043a;&#x0043e;&#x00433;&#x0043e;&#x00440;&#x00442;&#x00435; &#x00431;&#x0043e;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x0043e;&#x0043c;, &#x0043f;&#x00440;&#x0043e;&#x00436;&#x00438;&#x00432;&#x00430;&#x0044e;&#x00449;&#x00438;&#x00445; &#x00432; &#x00433;.&#x000a0;&#x00428;&#x00430;&#x0043d;&#x00445;&#x00430;&#x00439;.</p></sec><sec><title>&#x0041c;&#x00435;&#x00442;&#x0043e;&#x00434;&#x0044b;</title><p>&#x00412; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00438; &#x0043f;&#x00440;&#x00438;&#x0043d;&#x0044f;&#x0043b;&#x00438; &#x00443;&#x00447;&#x00430;&#x00441;&#x00442;&#x00438;&#x00435; &#x0043c;&#x00435;&#x00441;&#x00442;&#x0043d;&#x0044b;&#x00435; &#x00436;&#x00438;&#x00442;&#x00435;&#x0043b;&#x00438; 4&#x000a0;&#x00440;&#x00430;&#x00439;&#x0043e;&#x0043d;&#x0043e;&#x00432; &#x00428;&#x00430;&#x0043d;&#x00445;&#x00430;&#x0044f;&#x000a0;(&#x00438;&#x00437; 19), &#x00437;&#x00430;&#x00440;&#x00435;&#x00433;&#x00438;&#x00441;&#x00442;&#x00440;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00432; &#x0043e;&#x00434;&#x0043d;&#x0043e;&#x00439; &#x00438;&#x00437; &#x00447;&#x00435;&#x00442;&#x0044b;&#x00440;&#x00435;&#x00445; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x0043d;&#x0044b;&#x00445; &#x0043a;&#x0043b;&#x00438;&#x0043d;&#x00438;&#x0043a; &#x00432; &#x0043f;&#x00435;&#x00440;&#x00438;&#x0043e;&#x00434; &#x00441; 1&#x000a0;&#x0044f;&#x0043d;&#x00432;&#x00430;&#x00440;&#x0044f; 2004&#x000a0;&#x00433;&#x0043e;&#x00434;&#x00430; &#x0043f;&#x0043e; 31&#x000a0;&#x00434;&#x00435;&#x0043a;&#x00430;&#x00431;&#x00440;&#x0044f; 2008&#x000a0;&#x00433;&#x0043e;&#x00434;&#x00430;. &#x00421;&#x00431;&#x0043e;&#x00440; &#x00438;&#x00441;&#x00445;&#x0043e;&#x00434;&#x0043d;&#x0044b;&#x00445; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043e;&#x00441;&#x00443;&#x00449;&#x00435;&#x00441;&#x00442;&#x00432;&#x0043b;&#x0044f;&#x0043b;&#x00441;&#x0044f; &#x0043f;&#x00440;&#x00438; &#x0043f;&#x0043e;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043d;&#x00435;&#x0043c; &#x00434;&#x00438;&#x00430;&#x00433;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00438; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x00430;, &#x00430; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x0043a;&#x00430; &#x00441;&#x0043c;&#x00435;&#x00440;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x0043f;&#x00440;&#x0043e;&#x00432;&#x0043e;&#x00434;&#x00438;&#x0043b;&#x00430;&#x00441;&#x0044c; &#x00432; &#x0043f;&#x00435;&#x00440;&#x00438;&#x0043e;&#x00434; &#x00441; &#x0043c;&#x00430;&#x00440;&#x00442;&#x00430; &#x0043f;&#x0043e; &#x0043c;&#x00430;&#x00439;&#x000a0;2014&#x000a0;&#x00433;&#x0043e;&#x00434;&#x00430;. &#x00411;&#x0044b;&#x0043b;&#x00438; &#x00440;&#x00430;&#x00441;&#x00441;&#x00447;&#x00438;&#x00442;&#x00430;&#x0043d;&#x0044b; &#x00441;&#x00442;&#x00430;&#x0043d;&#x00434;&#x00430;&#x00440;&#x00442;&#x00438;&#x00437;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x0043f;&#x0043e;&#x0043a;&#x00430;&#x00437;&#x00430;&#x00442;&#x00435;&#x0043b;&#x00438; &#x00441;&#x0043c;&#x00435;&#x00440;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438;&#x000a0;(SMR) &#x00438; &#x0043f;&#x0043e;&#x0043a;&#x00430;&#x00437;&#x00430;&#x00442;&#x00435;&#x0043b;&#x00438; &#x0043b;&#x00435;&#x00442;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00434;&#x0043b;&#x0044f; &#x00432;&#x00441;&#x00435;&#x00445; &#x00443;&#x00447;&#x00430;&#x00441;&#x00442;&#x0043d;&#x00438;&#x0043a;&#x0043e;&#x00432; &#x00438; &#x0043f;&#x0043e;&#x00434;&#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;. &#x00414;&#x0043b;&#x0044f; &#x0043a;&#x0043e;&#x0043b;&#x00438;&#x00447;&#x00435;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0043e;&#x00433;&#x0043e; &#x0043e;&#x0043f;&#x00440;&#x00435;&#x00434;&#x00435;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x0043a;&#x0043e;&#x00440;&#x00440;&#x00435;&#x0043b;&#x0044f;&#x00446;&#x00438;&#x00438; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443; &#x00441;&#x0043e;&#x0043f;&#x00443;&#x00442;&#x00441;&#x00442;&#x00432;&#x00443;&#x0044e;&#x00449;&#x00438;&#x0043c;&#x00438; &#x00437;&#x00430;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;&#x0043c;&#x00438; &#x00438; &#x00441;&#x0043c;&#x00435;&#x00440;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0044c;&#x0044e; &#x0043f;&#x0043e; &#x00432;&#x00441;&#x00435;&#x0043c; &#x0043f;&#x00440;&#x00438;&#x00447;&#x00438;&#x0043d;&#x00430;&#x0043c; &#x00438; &#x0043e;&#x00442; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x00430; &#x00431;&#x0044b;&#x0043b;&#x00438; &#x00438;&#x00441;&#x0043f;&#x0043e;&#x0043b;&#x0044c;&#x00437;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0044b; &#x0043e;&#x00434;&#x0043d;&#x0043e;&#x00432;&#x00430;&#x00440;&#x00438;&#x00430;&#x0043d;&#x00442;&#x0043d;&#x00430;&#x0044f; &#x00438; &#x0043c;&#x0043d;&#x0043e;&#x00433;&#x0043e;&#x00432;&#x00430;&#x00440;&#x00438;&#x00430;&#x0043d;&#x00442;&#x0043d;&#x00430;&#x0044f; &#x0043c;&#x0043e;&#x00434;&#x00435;&#x0043b;&#x00438; &#x00440;&#x00435;&#x00433;&#x00440;&#x00435;&#x00441;&#x00441;&#x00438;&#x00438; &#x0041a;&#x0043e;&#x0043a;&#x00441;&#x00430;.</p></sec><sec><title>&#x00420;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0044b;</title><p>&#x00412; &#x0043a;&#x0043e;&#x00433;&#x0043e;&#x00440;&#x00442;&#x00435; &#x00431;&#x0044b;&#x0043b;&#x0043e; &#x00437;&#x00430;&#x00440;&#x00435;&#x00433;&#x00438;&#x00441;&#x00442;&#x00440;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043e; 4569&#x000a0;&#x00441;&#x00443;&#x00431;&#x0044a;&#x00435;&#x0043a;&#x00442;&#x0043e;&#x00432;. &#x00412; &#x00446;&#x00435;&#x0043b;&#x0043e;&#x0043c; &#x0043f;&#x0043e; &#x0043a;&#x0043e;&#x00433;&#x0043e;&#x00440;&#x00442;&#x00435; SMR &#x00434;&#x0043b;&#x0044f; &#x00441;&#x0043c;&#x00435;&#x00440;&#x00442;&#x00438; &#x0043e;&#x00442; &#x00432;&#x00441;&#x00435;&#x00445; &#x00441;&#x0043b;&#x00443;&#x00447;&#x00430;&#x00435;&#x00432; &#x00441;&#x0043e;&#x00441;&#x00442;&#x00430;&#x00432;&#x00438;&#x0043b; 5,2&#x000a0;(95%-&#x00439; &#x00434;&#x0043e;&#x00432;&#x00435;&#x00440;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x00438;&#x0043d;&#x00442;&#x00435;&#x00440;&#x00432;&#x00430;&#x0043b;, &#x00414;&#x00418;: 4,8&#x02013;5,6). &#x00414;&#x0043b;&#x0044f; &#x0043c;&#x00443;&#x00436;&#x00447;&#x00438;&#x0043d; SMR &#x00431;&#x0044b;&#x0043b; &#x00432;&#x0044b;&#x00448;&#x00435;, &#x00447;&#x00435;&#x0043c; &#x00434;&#x0043b;&#x0044f; &#x00436;&#x00435;&#x0043d;&#x00449;&#x00438;&#x0043d;&#x000a0;(6,1 &#x0043f;&#x00440;&#x0043e;&#x00442;&#x00438;&#x00432;&#x000a0;3,0). &#x00421; &#x00443;&#x00447;&#x00435;&#x00442;&#x0043e;&#x0043c; &#x0043f;&#x0043e;&#x0043f;&#x00440;&#x00430;&#x00432;&#x0043a;&#x00438; &#x0043d;&#x00430; &#x00432;&#x0043e;&#x00437;&#x00440;&#x00430;&#x00441;&#x00442; &#x00438; &#x0043f;&#x0043e;&#x0043b; &#x0043e;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00439; &#x00440;&#x00438;&#x00441;&#x0043a;&#x000a0;(&#x0041e;&#x00420;) &#x00434;&#x0043b;&#x0044f; &#x00441;&#x0043c;&#x00435;&#x00440;&#x00442;&#x00438; &#x0043f;&#x0043e; &#x00432;&#x00441;&#x00435;&#x0043c; &#x0043f;&#x00440;&#x00438;&#x00447;&#x00438;&#x0043d;&#x00430;&#x0043c; &#x00431;&#x0044b;&#x0043b; &#x00437;&#x0043d;&#x00430;&#x00447;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0043e; &#x00432;&#x0044b;&#x00448;&#x00435; &#x00434;&#x0043b;&#x0044f; &#x0043b;&#x00438;&#x00446;, &#x00440;&#x00430;&#x0043d;&#x00435;&#x00435; &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00430;&#x00432;&#x00448;&#x00438;&#x00445; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00435;&#x000a0;(&#x0041e;&#x00420;:&#x000a0;1,26; 95%-&#x00439; &#x00414;&#x00418;:&#x000a0;1,08&#x02013;1,49), &#x00438; &#x00434;&#x0043b;&#x0044f; &#x0043b;&#x00438;&#x00446; &#x00441; &#x0043f;&#x0043e;&#x0043b;&#x0043e;&#x00436;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x0043c; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0043e;&#x0043c; &#x0043c;&#x00438;&#x0043a;&#x00440;&#x0043e;&#x00441;&#x0043a;&#x0043e;&#x0043f;&#x00438;&#x00438; &#x0043c;&#x00430;&#x00437;&#x0043a;&#x00430; &#x0043c;&#x0043e;&#x0043a;&#x00440;&#x0043e;&#x00442;&#x0044b;&#x000a0;(&#x0041e;&#x00420;:&#x000a0;1,55; 95%-&#x00439; &#x00414;&#x00418;:&#x000a0;1,35&#x02013;1,78). &#x00420;&#x00438;&#x00441;&#x0043a; &#x00441;&#x0043c;&#x00435;&#x00440;&#x00442;&#x00438; &#x0043e;&#x00442; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x00430; &#x00431;&#x0044b;&#x0043b; &#x00442;&#x00430;&#x0043a;&#x00436;&#x00435; &#x00437;&#x0043d;&#x00430;&#x00447;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0043e; &#x00432;&#x0044b;&#x00448;&#x00435; &#x00434;&#x0043b;&#x0044f; &#x0043b;&#x00438;&#x00446;, &#x00440;&#x00430;&#x0043d;&#x00435;&#x00435; &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00430;&#x00432;&#x00448;&#x00438;&#x00445; &#x0043b;&#x00435;&#x00447;&#x00435;&#x0043d;&#x00438;&#x00435;&#x000a0;(&#x0041e;&#x00420;:&#x000a0;1,88; 95%-&#x00439; &#x00414;&#x00418;: 1,24&#x02013;2,86), &#x00438; &#x00434;&#x0043b;&#x0044f; &#x0043b;&#x00438;&#x00446; &#x00441; &#x0043f;&#x0043e;&#x0043b;&#x0043e;&#x00436;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x0043c; &#x00440;&#x00435;&#x00437;&#x00443;&#x0043b;&#x0044c;&#x00442;&#x00430;&#x00442;&#x0043e;&#x0043c; &#x0043c;&#x00438;&#x0043a;&#x00440;&#x0043e;&#x00441;&#x0043a;&#x0043e;&#x0043f;&#x00438;&#x00438; &#x0043c;&#x00430;&#x00437;&#x0043a;&#x00430;&#x000a0;(&#x0041e;&#x00420;:&#x000a0;3,16;&#x000a0;95%-&#x00439; &#x00414;&#x00418;:&#x000a0;2,06&#x02013;4,87).</p></sec><sec><title>&#x00412;&#x0044b;&#x00432;&#x0043e;&#x00434;</title><p>&#x00414;&#x0043b;&#x0044f; &#x0043b;&#x00438;&#x00446; &#x00441; &#x00442;&#x00443;&#x00431;&#x00435;&#x00440;&#x0043a;&#x00443;&#x0043b;&#x00435;&#x00437;&#x0043e;&#x0043c;, &#x0043f;&#x00440;&#x0043e;&#x00436;&#x00438;&#x00432;&#x00430;&#x0044e;&#x00449;&#x00438;&#x00445; &#x00432; &#x00428;&#x00430;&#x0043d;&#x00445;&#x00430;&#x00435;, &#x00441;&#x00443;&#x00449;&#x00435;&#x00441;&#x00442;&#x00432;&#x00443;&#x00435;&#x00442; &#x0043f;&#x0043e;&#x00432;&#x0044b;&#x00448;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x00439; &#x00440;&#x00438;&#x00441;&#x0043a; &#x00441;&#x0043c;&#x00435;&#x00440;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438;. &#x00420;&#x00430;&#x0043d;&#x0043d;&#x0044f;&#x0044f; &#x00434;&#x00438;&#x00430;&#x00433;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438;&#x0043a;&#x00430; &#x00438; &#x00431;&#x0043e;&#x0043b;&#x00435;&#x00435; &#x00441;&#x00442;&#x00440;&#x0043e;&#x00433;&#x00438;&#x00439; &#x0043f;&#x0043e;&#x00441;&#x0043b;&#x00435;&#x00434;&#x00443;&#x0044e;&#x00449;&#x00438;&#x00439; &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x0044c; &#x0043c;&#x0043e;&#x00433;&#x00443;&#x00442; &#x00441;&#x0043f;&#x0043e;&#x00441;&#x0043e;&#x00431;&#x00441;&#x00442;&#x00432;&#x0043e;&#x00432;&#x00430;&#x00442;&#x0044c; &#x00441;&#x0043d;&#x00438;&#x00436;&#x00435;&#x0043d;&#x00438;&#x0044e; &#x00441;&#x0043c;&#x00435;&#x00440;&#x00442;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00432; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0043e;&#x00439; &#x00433;&#x00440;&#x00443;&#x0043f;&#x0043f;&#x00435; &#x0043b;&#x00438;&#x00446;.</p></sec></trans-abstract></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>China has approximately 1&#x000a0;million new cases of tuberculosis per year,<xref rid="R1" ref-type="bibr"><sup>1</sup></xref><sup>&#x02013;</sup><xref rid="R3" ref-type="bibr"><sup>3</sup></xref> resulting in a substantial burden of premature mortality.<xref rid="R2" ref-type="bibr"><sup>2</sup></xref> Several factors are known to increase the risk of tuberculosis-associated mortality, including drug resistance, disease severity, irregular or incomplete treatment, human immunodeficiency virus (HIV) infection, smoking and alcoholism.<xref rid="R4" ref-type="bibr"><sup>4</sup></xref> Multidrug-resistant (MDR) tuberculosis poses a major threat to tuberculosis control. A national survey done in 2008 found that 5.7% of people newly diagnosed with tuberculosis, and 25.6% of those who had previously been treated, had MDR-tuberculosis.<xref rid="R5" ref-type="bibr"><sup>5</sup></xref> In Shanghai, China, people being treated for tuberculosis had a case-fatality rate (CFR) of 5.5% in 2008,<xref rid="R6" ref-type="bibr"><sup>6</sup></xref> and in 2010 another national survey reported a CFR of 5.1%.<xref rid="R7" ref-type="bibr"><sup>7</sup></xref> The purpose of the present study was to determine the mortality rate and excess mortality in a cohort of people with tuberculosis who were registered in four districts of Shanghai from 2004 to 2008 and to identify groups in this cohort at high risk of death.</p></sec><sec sec-type="methods"><title>Methods</title><p>The study sample consisted of local residents from four districts in Shanghai City: Yangpu, Pudong, Putuo and Songjiang, with a total population of 9.23&#x000a0;million in 2014. The districts were chosen based on geographic location and tuberculosis notifications. Our study population consisted of 5001 local participants who were registered in tuberculosis clinics under the national tuberculosis programme between January 1, 2004 and December 31, 2008. We included both newly diagnosed and previously treated participants.</p><p>Beginning in the 1990s, the national tuberculosis programme implemented a mandatory reporting system for people with tuberculosis in Shanghai. Each person with suspected tuberculosis who seeks health care in facilities in Shanghai is referred to a specialized tuberculosis hospital or clinic where chest X-rays, sputum smears and cultures are done to confirm the diagnosis. Three sputum specimens are routinely collected from each person. People with bacteriological confirmation or abnormal chest X-ray results are routinely treated at a tuberculosis reference hospital or clinic. All <italic>M. tuberculosis</italic> isolates were sent to the tuberculosis reference laboratory at the Shanghai Center for Disease Control and Prevention (CDC) or to the Shanghai Pulmonary Hospital for drug susceptibility testing.</p><p>The ethics committee of the School of Public Health of Fudan University approved the study. All participants provided written informed consent to allow their information to be stored and used for research. The study was a sub-study conducted within a larger underlying study.</p><sec><title>Definitions</title><p>An isolate was considered as MDR-tuberculosis if it was resistant to both isoniazid and rifampin. Cause of death was based on information in the death certificate and classified according to the <italic>International Statistical Classification of Diseases and Related Health Problems, 10th Revision</italic> (ICD-10).<xref rid="R8" ref-type="bibr"><sup>8</sup></xref> Deaths among people with both HIV and tuberculosis are classified as deaths from HIV in ICD-10. Due to a low percentage of HIV-positive people in the study population (0.28&#x02013;3.30%),<xref rid="R9" ref-type="bibr"><sup>9</sup></xref><sup>,</sup><xref rid="R10" ref-type="bibr"><sup>10</sup></xref> all participants were assumed to be HIV-negative. The case-fatality rate is defined as the risk of death from tuberculosis among people diagnosed with active tuberculosis.<xref rid="R11" ref-type="bibr"><sup>11</sup></xref></p><p>Mortality was measured as: (i)&#x000a0;the standardized mortality ratio (SMR; see <xref ref-type="boxed-text" rid="B1">Box&#x000a0;1</xref>); and (ii)&#x000a0;the case-fatality rate at 1, 5 and 10&#x000a0;years from the start of treatment. The case-fatality rate was estimated as the number of deaths divided by the total number of people with active tuberculosis.</p><boxed-text id="B1" position="float" orientation="portrait"><label>Box&#x000a0;1</label><caption><title>Estimating tuberculosis mortality</title></caption><p>In 2002, the World Health Organization (WHO) defined any death of a tuberculosis patient during treatment as attributable to tuberculosis, irrespective of the final cause of death.<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> As a result, several recent studies used all-cause mortality as a surrogate marker of mortality attributable to tuberculosis.<xref rid="R13" ref-type="bibr"><sup>13</sup></xref></p><p>Since 2013, WHO Global Tuberculosis Reports have defined mortality from tuberculosis as any death caused by tuberculosis in HIV-negative individuals.<xref rid="R2" ref-type="bibr"><sup>2</sup></xref> When reported as a rate, tuberculosis mortality has typically been expressed as a person-time mortality rate or more commonly as a case-fatality rate (the risk of death from tuberculosis among individuals with active tuberculosis) within a specific time period. However, the case-fatality rates reported for tuberculosis, which range from 12% to 44%, cannot be compared among studies because they were determined as cumulative mortality using different follow-up durations.<xref rid="R4" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="R14" ref-type="bibr"><sup>14</sup></xref> In addition, the tuberculosis mortality rate is affected by the baseline mortality rate of the study population.<xref rid="R13" ref-type="bibr"><sup>13</sup></xref><sup>,</sup><xref rid="R15" ref-type="bibr"><sup>15</sup></xref></p><p>A better, though indirect, measure of tuberculosis mortality is the standardized mortality ratio (SMR). The SMR is defined as the observed mortality in people with tuberculosis relative to the expected mortality based on the age-specific mortality rates in a standard population. We used the national population of China in 2013 as our standard population.<xref rid="R16" ref-type="bibr"><sup>16</sup></xref></p></boxed-text></sec><sec><title>Baseline survey</title><p>Inclusion criteria were as follows: registered in a tuberculosis clinic under the national tuberculosis programme between January 1, 2004 and December 31, 2008; having household registration or continuous residence at the study site for at least 6&#x000a0;months in the previous year; and provision of written informed consent by the participants or their relatives. Baseline data were collected at the most recent diagnosis of tuberculosis (between 2002 and 2008) and included name, age, sex, residential address, category of treatment and date of registration from the national tuberculosis programme register. Comorbidities, behavioural risk factors (such as smoking) and other data were extracted from paper copies of medical records.</p></sec><sec><title>Follow-up</title><p>From March to May 2014, health workers visited the households of all participants at least once and interviewed participants or their close relatives who lived in the same household. Deaths were reported by household members and mortality data, including date of death, were collected from death certificates. For quality control, 10% of subjects were re-interviewed; trained public health workers checked data by telephone or in direct visits. Participants were followed up for a range of 1886 to 5205 days (5.17 to 10.67 years), starting from registration to the last follow-up in 2014 or until the date of death.</p></sec><sec><title>Regression analysis</title><p>Univariate and multivariate Cox regression models were used to identify significant co-morbidities during treatment for tuberculosis that were associated with all-cause mortality in SPSS statistical software version 16.0 (SPSS Inc., Chicago, United States of America). Hazard ratios (HR), 95% confidence intervals (CI), and <italic>P</italic>-values were calculated to assess the significance of associations.</p></sec></sec><sec sec-type="results"><title>Results</title><p>A total of 5001 participants met our inclusion criteria (<xref ref-type="table" rid="T1">Table&#x000a0;1</xref>). Of these, 432 were excluded from analysis because they were misdiagnosed, declined to participate in the follow-up, relocated to a district without a tuberculosis register or failed to provide a new address. Of 4569 participants with successful follow-up (91.4%), 3396 were men (74.3%) and 1173 were women (25.7%; <xref ref-type="table" rid="T1">Table&#x000a0;1</xref>). Among the participants, 3601 (78.8%) survived the entire follow-up period from the start of treatment and 968 (21.2%) died. Men were more likely than women to have lung cavitation (29.4% versus 20.3%; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), two or more comorbidities (3.0% versus 1.5%, <italic>P</italic>&#x02009;=&#x02009;0.008) and be smear-positive (48.0% versus 39.1%, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), but were less likely to have received previous treatment (10.9% versus 35.5%, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001).</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Mortality in tuberculosis patients, Shanghai, China, 2004&#x02013;2014</title></caption><table frame="hsides" rules="groups"><col width="134" span="1"/><col width="46" span="1"/><col width="86" span="1"/><col width="66" span="1"/><col width="86" span="1"/><col width="64" span="1"/><col width="98" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Group</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">No.</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Person-years follow-up</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Observed deaths</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Mortality rate per 1&#x02009;000 person-years</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Expected deaths<sup>a</sup></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">SMR<sup>b</sup> (95% CI)<sup>c</sup></th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>All</bold></td><td valign="top" align="center" rowspan="1" colspan="1">4569</td><td valign="top" align="center" rowspan="1" colspan="1">29&#x02009;744</td><td valign="top" align="center" rowspan="1" colspan="1">968</td><td valign="top" align="center" rowspan="1" colspan="1">32.5</td><td valign="top" align="center" rowspan="1" colspan="1">282.7</td><td valign="top" align="center" rowspan="1" colspan="1">5.2 (4.8&#x02013;5.6)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Age group, years</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">0&#x02013;19</td><td valign="top" align="center" rowspan="1" colspan="1">46</td><td valign="top" align="center" rowspan="1" colspan="1">301</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.0 (0.0&#x02013;2.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">20&#x02013;39</td><td valign="top" align="center" rowspan="1" colspan="1">1007</td><td valign="top" align="center" rowspan="1" colspan="1">7471</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">2.0</td><td valign="top" align="center" rowspan="1" colspan="1">5.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.3 (0.2&#x02013;0.5)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">40&#x02013;59</td><td valign="top" align="center" rowspan="1" colspan="1">1771</td><td valign="top" align="center" rowspan="1" colspan="1">12&#x02009;500</td><td valign="top" align="center" rowspan="1" colspan="1">175</td><td valign="top" align="center" rowspan="1" colspan="1">14.0</td><td valign="top" align="center" rowspan="1" colspan="1">58.6</td><td valign="top" align="center" rowspan="1" colspan="1">2.3 (1.9&#x02013;2.65)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">60&#x02013;79</td><td valign="top" align="center" rowspan="1" colspan="1">1212</td><td valign="top" align="center" rowspan="1" colspan="1">7280</td><td valign="top" align="center" rowspan="1" colspan="1">411</td><td valign="top" align="center" rowspan="1" colspan="1">56.5</td><td valign="top" align="center" rowspan="1" colspan="1">285.8</td><td valign="top" align="center" rowspan="1" colspan="1">9.1 (8.2&#x02013;10.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x02265;&#x02009;&#x02009;80</td><td valign="top" align="center" rowspan="1" colspan="1">525</td><td valign="top" align="center" rowspan="1" colspan="1">2101</td><td valign="top" align="center" rowspan="1" colspan="1">363</td><td valign="top" align="center" rowspan="1" colspan="1">172.8</td><td valign="top" align="center" rowspan="1" colspan="1">401.4</td><td valign="top" align="center" rowspan="1" colspan="1">27.9 (25.1&#x02013;30.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">46</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">87.9</td><td valign="top" align="center" rowspan="1" colspan="1">0.5</td><td valign="top" align="center" rowspan="1" colspan="1">14.2 (3.9&#x02013;36.3)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Sex</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Male</td><td valign="top" align="center" rowspan="1" colspan="1">3396</td><td valign="top" align="center" rowspan="1" colspan="1">21&#x02009;628</td><td valign="top" align="center" rowspan="1" colspan="1">819</td><td valign="top" align="center" rowspan="1" colspan="1">37.9</td><td valign="top" align="center" rowspan="1" colspan="1">236.9</td><td valign="top" align="center" rowspan="1" colspan="1">6.1 (5.7&#x02013;6.5)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Female</td><td valign="top" align="center" rowspan="1" colspan="1">1173</td><td valign="top" align="center" rowspan="1" colspan="1">8116</td><td valign="top" align="center" rowspan="1" colspan="1">149</td><td valign="top" align="center" rowspan="1" colspan="1">18.4</td><td valign="top" align="center" rowspan="1" colspan="1">62.9</td><td valign="top" align="center" rowspan="1" colspan="1">3.0 (2.5&#x02013;3.5)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Diagnosis</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Secondary pulmonary</td><td valign="top" align="center" rowspan="1" colspan="1">4108</td><td valign="top" align="center" rowspan="1" colspan="1">26&#x02009;698</td><td valign="top" align="center" rowspan="1" colspan="1">882</td><td valign="top" align="center" rowspan="1" colspan="1">33.0</td><td valign="top" align="center" rowspan="1" colspan="1">254.7</td><td valign="top" align="center" rowspan="1" colspan="1">5.3 (5.0&#x02013;5.7)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Primary pulmonary</td><td valign="top" align="center" rowspan="1" colspan="1">50</td><td valign="top" align="center" rowspan="1" colspan="1">332</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">9.0</td><td valign="top" align="center" rowspan="1" colspan="1">3.1</td><td valign="top" align="center" rowspan="1" colspan="1">1.5 (0.3&#x02013;4.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Disseminated pulmonary</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">70</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">114.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.9</td><td valign="top" align="center" rowspan="1" colspan="1">18.5 (8.0&#x02013;36.5)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Extra-pulmonary</td><td valign="top" align="center" rowspan="1" colspan="1">367</td><td valign="top" align="center" rowspan="1" colspan="1">2475</td><td valign="top" align="center" rowspan="1" colspan="1">71</td><td valign="top" align="center" rowspan="1" colspan="1">28.7</td><td valign="top" align="center" rowspan="1" colspan="1">22.8</td><td valign="top" align="center" rowspan="1" colspan="1">4.6 (3.6&#x02013;5.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Other</td><td valign="top" align="center" rowspan="1" colspan="1">29</td><td valign="top" align="center" rowspan="1" colspan="1">169</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">23.6</td><td valign="top" align="center" rowspan="1" colspan="1">1.8</td><td valign="top" align="center" rowspan="1" colspan="1">3.8 (1.0&#x02013;9.8)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Treatment management</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Directly-observed</td><td valign="top" align="center" rowspan="1" colspan="1">1152</td><td valign="top" align="center" rowspan="1" colspan="1">7702</td><td valign="top" align="center" rowspan="1" colspan="1">227</td><td valign="top" align="center" rowspan="1" colspan="1">29.5</td><td valign="top" align="center" rowspan="1" colspan="1">71.4</td><td valign="top" align="center" rowspan="1" colspan="1">4.8 (4.2&#x02013;5.4)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Self-administered</td><td valign="top" align="center" rowspan="1" colspan="1">30</td><td valign="top" align="center" rowspan="1" colspan="1">261</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">15.3</td><td valign="top" align="center" rowspan="1" colspan="1">1.9</td><td valign="top" align="center" rowspan="1" colspan="1">2.5 (0.7&#x02013;6.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hospitalized</td><td valign="top" align="center" rowspan="1" colspan="1">1907</td><td valign="top" align="center" rowspan="1" colspan="1">11&#x02009;922</td><td valign="top" align="center" rowspan="1" colspan="1">504</td><td valign="top" align="center" rowspan="1" colspan="1">42.3</td><td valign="top" align="center" rowspan="1" colspan="1">118.2</td><td valign="top" align="center" rowspan="1" colspan="1">6.8 (6.2&#x02013;7.4)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Family-observed</td><td valign="top" align="center" rowspan="1" colspan="1">1250</td><td valign="top" align="center" rowspan="1" colspan="1">8491</td><td valign="top" align="center" rowspan="1" colspan="1">197</td><td valign="top" align="center" rowspan="1" colspan="1">23.2</td><td valign="top" align="center" rowspan="1" colspan="1">77.5</td><td valign="top" align="center" rowspan="1" colspan="1">3.7 (3.2&#x02013;4.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">230</td><td valign="top" align="center" rowspan="1" colspan="1">1368</td><td valign="top" align="center" rowspan="1" colspan="1">36</td><td valign="top" align="center" rowspan="1" colspan="1">26.3</td><td valign="top" align="center" rowspan="1" colspan="1">14.3</td><td valign="top" align="center" rowspan="1" colspan="1">4.2 (3.0&#x02013;5.9)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Previously treated</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">785</td><td valign="top" align="center" rowspan="1" colspan="1">4953</td><td valign="top" align="center" rowspan="1" colspan="1">202</td><td valign="top" align="center" rowspan="1" colspan="1">40.8</td><td valign="top" align="center" rowspan="1" colspan="1">48.7</td><td valign="top" align="center" rowspan="1" colspan="1">6.6 (5.7&#x02013;7.6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">3784</td><td valign="top" align="center" rowspan="1" colspan="1">24&#x02009;791</td><td valign="top" align="center" rowspan="1" colspan="1">706</td><td valign="top" align="center" rowspan="1" colspan="1">28.5</td><td valign="top" align="center" rowspan="1" colspan="1">234.6</td><td valign="top" align="center" rowspan="1" colspan="1">4.6 (4.3&#x02013;4.9)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>MDR-tuberculosis</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">41</td><td valign="top" align="center" rowspan="1" colspan="1">199</td><td valign="top" align="center" rowspan="1" colspan="1">17</td><td valign="top" align="center" rowspan="1" colspan="1">85.5</td><td valign="top" align="center" rowspan="1" colspan="1">2.5</td><td valign="top" align="center" rowspan="1" colspan="1">13.8 (8.0&#x02013;22.1)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">1449</td><td valign="top" align="center" rowspan="1" colspan="1">9671</td><td valign="top" align="center" rowspan="1" colspan="1">354</td><td valign="top" align="center" rowspan="1" colspan="1">36.6</td><td valign="top" align="center" rowspan="1" colspan="1">89.8</td><td valign="top" align="center" rowspan="1" colspan="1">5.9 (5.3&#x02013;6.6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">3079</td><td valign="top" align="center" rowspan="1" colspan="1">19&#x02009;874</td><td valign="top" align="center" rowspan="1" colspan="1">597</td><td valign="top" align="center" rowspan="1" colspan="1">30.0</td><td valign="top" align="center" rowspan="1" colspan="1">190.9</td><td valign="top" align="center" rowspan="1" colspan="1">4.8 (4.5&#x02013;5.2)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Sputum smear test</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">2341</td><td valign="top" align="center" rowspan="1" colspan="1">12&#x02009;602</td><td valign="top" align="center" rowspan="1" colspan="1">334</td><td valign="top" align="center" rowspan="1" colspan="1">26.5</td><td valign="top" align="center" rowspan="1" colspan="1">145.1</td><td valign="top" align="center" rowspan="1" colspan="1">4.3 (3.8&#x02013;4.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">2089</td><td valign="top" align="center" rowspan="1" colspan="1">16&#x02009;189</td><td valign="top" align="center" rowspan="1" colspan="1">616</td><td valign="top" align="center" rowspan="1" colspan="1">38.0</td><td valign="top" align="center" rowspan="1" colspan="1">129.5</td><td valign="top" align="center" rowspan="1" colspan="1">6.1 (5.7&#x02013;6.6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">139</td><td valign="top" align="center" rowspan="1" colspan="1">952</td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">18.9</td><td valign="top" align="center" rowspan="1" colspan="1">8.6</td><td valign="top" align="center" rowspan="1" colspan="1">3.0 (1.8&#x02013;4.8)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Cavitation</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">1235</td><td valign="top" align="center" rowspan="1" colspan="1">7892</td><td valign="top" align="center" rowspan="1" colspan="1">257</td><td valign="top" align="center" rowspan="1" colspan="1">32.6</td><td valign="top" align="center" rowspan="1" colspan="1">203.2</td><td valign="top" align="center" rowspan="1" colspan="1">5.3 (4.6&#x02013;5.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">3277</td><td valign="top" align="center" rowspan="1" colspan="1">21&#x02009;526</td><td valign="top" align="center" rowspan="1" colspan="1">691</td><td valign="top" align="center" rowspan="1" colspan="1">32.1</td><td valign="top" align="center" rowspan="1" colspan="1">76.6</td><td valign="top" align="center" rowspan="1" colspan="1">5.2 (4.8&#x02013;5.6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">57</td><td valign="top" align="center" rowspan="1" colspan="1">326</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">61.4</td><td valign="top" align="center" rowspan="1" colspan="1">3.5</td><td valign="top" align="center" rowspan="1" colspan="1">9.9 (6.0&#x02013;15.3)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Comorbidity</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Diabetes</td><td valign="top" align="center" rowspan="1" colspan="1">473</td><td valign="top" align="center" rowspan="1" colspan="1">2864</td><td valign="top" align="center" rowspan="1" colspan="1">129</td><td valign="top" align="center" rowspan="1" colspan="1">45.0</td><td valign="top" align="center" rowspan="1" colspan="1">29.3</td><td valign="top" align="center" rowspan="1" colspan="1">7.3 (6.1&#x02013;8.6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">COPD</td><td valign="top" align="center" rowspan="1" colspan="1">22</td><td valign="top" align="center" rowspan="1" colspan="1">100</td><td valign="top" align="center" rowspan="1" colspan="1">14</td><td valign="top" align="center" rowspan="1" colspan="1">140.0</td><td valign="top" align="center" rowspan="1" colspan="1">1.4</td><td valign="top" align="center" rowspan="1" colspan="1">22.6 (12.3&#x02013;37.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hypertension</td><td valign="top" align="center" rowspan="1" colspan="1">67</td><td valign="top" align="center" rowspan="1" colspan="1">385</td><td valign="top" align="center" rowspan="1" colspan="1">28</td><td valign="top" align="center" rowspan="1" colspan="1">72.8</td><td valign="top" align="center" rowspan="1" colspan="1">4.2</td><td valign="top" align="center" rowspan="1" colspan="1">11.7 (7.8&#x02013;17.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chronic bronchitis</td><td valign="top" align="center" rowspan="1" colspan="1">87</td><td valign="top" align="center" rowspan="1" colspan="1">418</td><td valign="top" align="center" rowspan="1" colspan="1">46</td><td valign="top" align="center" rowspan="1" colspan="1">110.0</td><td valign="top" align="center" rowspan="1" colspan="1">5.4</td><td valign="top" align="center" rowspan="1" colspan="1">17.7 (13.0&#x02013;23.7)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cancer</td><td valign="top" align="center" rowspan="1" colspan="1">36</td><td valign="top" align="center" rowspan="1" colspan="1">134</td><td valign="top" align="center" rowspan="1" colspan="1">25</td><td valign="top" align="center" rowspan="1" colspan="1">186.8</td><td valign="top" align="center" rowspan="1" colspan="1">2.2</td><td valign="top" align="center" rowspan="1" colspan="1">30.1 (19.5&#x02013;44.5)</td></tr></tbody></table><table-wrap-foot><p>CI: confidence interval; COPD: chronic-obstructive pulmonary disease; MDR: multidrug-resistant; SMR: standardized mortality ratio.</p><p><sup>a</sup> Calculated by multiplying the number of people with tuberculosis and age specific mortality rates of general population.<xref rid="R16" ref-type="bibr"><sup>16</sup></xref></p><p><sup>b</sup> Observed divided by expected mortality.</p><p><sup>c</sup> Calculated assuming a Poisson distribution.</p></table-wrap-foot></table-wrap><p>The overall SMR was 5.2 (95% CI: 4.8&#x02013;5.6); the SMR increased with age in our cohort. Among participants who were 20&#x02013;39 years-old, the SMR was 0.3 (i.e. lower than the general population), but the SMR increased to 27.9 for participants older than 79 years. Men had a higher SMR than women (6.1 versus 3.0). Participants with disseminated pulmonary disease had a higher SMR (18.5) than those with primary pulmonary disease (1.5) and secondary pulmonary disease (5.3). Previously treated participants had a higher SMR than participants who were undergoing their first treatment for tuberculosis (6.6 versus 4.6). Participants with comorbidities also had high SMRs, especially those with chronic obstructive pulmonary disease (COPD) (22.6) and cancer (30.1).</p><p>The 1, 5 and 10&#x000a0;year case-fatality rates were 7.48%, 17.20%, and 21.23%, respectively (<xref ref-type="table" rid="T2">Table&#x000a0;2</xref>). Participants with disseminated pulmonary disease had the highest 1&#x000a0;year case-fatality rate (40.00%), whereas those with cancer had the highest 5&#x000a0;year case-fatality rate (61.11%). The 5&#x000a0;year case-fatality rate was also high for participants older than 79 years (58.89%), with COPD (45.45%), chronic bronchitis (44.83%) or MDR-tuberculosis (39.02%). At the 10 year follow up, the case-fatality rate was highest for participants with cancer (69.44%) or COPD (63.64%) and was also high for those aged 80 years and older (69.02%).</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Cumulative case-fatality rates in tuberculosis patients, Shanghai, China, 2004&#x02013;2014</title></caption><table frame="hsides" rules="groups"><col width="176" span="1"/><col width="71" span="1"/><col width="56" span="1"/><col width="64" span="1"/><col width="73" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Subgroup</th><th rowspan="2" valign="top" align="center" scope="col" colspan="1">No.</th><th colspan="3" valign="top" align="center" scope="colgroup" rowspan="1">Cumulative case-fatality rate, (%)<hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">1 year</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">5 years</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">10 years</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"><bold>All</bold></td><td valign="top" align="center" rowspan="1" colspan="1">4569</td><td valign="top" align="center" rowspan="1" colspan="1">7.48</td><td valign="top" align="center" rowspan="1" colspan="1">17.20</td><td valign="top" align="center" rowspan="1" colspan="1">21.23</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Age group, years</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">0&#x02013;19</td><td valign="top" align="center" rowspan="1" colspan="1">46</td><td valign="top" align="center" rowspan="1" colspan="1">0.00</td><td valign="top" align="center" rowspan="1" colspan="1">0.00</td><td valign="top" align="center" rowspan="1" colspan="1">0.00</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">20&#x02013;39</td><td valign="top" align="center" rowspan="1" colspan="1">1007</td><td valign="top" align="center" rowspan="1" colspan="1">0.40</td><td valign="top" align="center" rowspan="1" colspan="1">1.09</td><td valign="top" align="center" rowspan="1" colspan="1">1.39</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">40&#x02013;59</td><td valign="top" align="center" rowspan="1" colspan="1">1771</td><td valign="top" align="center" rowspan="1" colspan="1">3.12</td><td valign="top" align="center" rowspan="1" colspan="1">8.56</td><td valign="top" align="center" rowspan="1" colspan="1">9.59</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">60&#x02013;79</td><td valign="top" align="center" rowspan="1" colspan="1">1212</td><td valign="top" align="center" rowspan="1" colspan="1">10.96</td><td valign="top" align="center" rowspan="1" colspan="1">25.75</td><td valign="top" align="center" rowspan="1" colspan="1">33.89</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x02265;&#x02009;80</td><td valign="top" align="center" rowspan="1" colspan="1">525</td><td valign="top" align="center" rowspan="1" colspan="1">28.49</td><td valign="top" align="center" rowspan="1" colspan="1">58.89</td><td valign="top" align="center" rowspan="1" colspan="1">69.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">12.50</td><td valign="top" align="center" rowspan="1" colspan="1">50.00</td><td valign="top" align="center" rowspan="1" colspan="1">50.00</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Sex</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Male</td><td valign="top" align="center" rowspan="1" colspan="1">3396</td><td valign="top" align="center" rowspan="1" colspan="1">8.73</td><td valign="top" align="center" rowspan="1" colspan="1">19.73</td><td valign="top" align="center" rowspan="1" colspan="1">23.96</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Female</td><td valign="top" align="center" rowspan="1" colspan="1">1173</td><td valign="top" align="center" rowspan="1" colspan="1">3.93</td><td valign="top" align="center" rowspan="1" colspan="1">10.00</td><td valign="top" align="center" rowspan="1" colspan="1">12.48</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Diagnosis</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Secondary pulmonary</td><td valign="top" align="center" rowspan="1" colspan="1">4108</td><td valign="top" align="center" rowspan="1" colspan="1">7.45</td><td valign="top" align="center" rowspan="1" colspan="1">17.60</td><td valign="top" align="center" rowspan="1" colspan="1">21.28</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Primary pulmonary</td><td valign="top" align="center" rowspan="1" colspan="1">50</td><td valign="top" align="center" rowspan="1" colspan="1">4.00</td><td valign="top" align="center" rowspan="1" colspan="1">6.00</td><td valign="top" align="center" rowspan="1" colspan="1">6.00</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Disseminated pulmonary</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">40.00</td><td valign="top" align="center" rowspan="1" colspan="1">46.67</td><td valign="top" align="center" rowspan="1" colspan="1">53.33</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Extra-pulmonary</td><td valign="top" align="center" rowspan="1" colspan="1">367</td><td valign="top" align="center" rowspan="1" colspan="1">6.81</td><td valign="top" align="center" rowspan="1" colspan="1">12.81</td><td valign="top" align="center" rowspan="1" colspan="1">19.35</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Other</td><td valign="top" align="center" rowspan="1" colspan="1">29</td><td valign="top" align="center" rowspan="1" colspan="1">6.90</td><td valign="top" align="center" rowspan="1" colspan="1">13.79</td><td valign="top" align="center" rowspan="1" colspan="1">13.79</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Clinical management</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Directly-observed</td><td valign="top" align="center" rowspan="1" colspan="1">1152</td><td valign="top" align="center" rowspan="1" colspan="1">5.47</td><td valign="top" align="center" rowspan="1" colspan="1">15.36</td><td valign="top" align="center" rowspan="1" colspan="1">19.44</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Self-administered</td><td valign="top" align="center" rowspan="1" colspan="1">30</td><td valign="top" align="center" rowspan="1" colspan="1">0.00</td><td valign="top" align="center" rowspan="1" colspan="1">6.67</td><td valign="top" align="center" rowspan="1" colspan="1">13.33</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hospitalized</td><td valign="top" align="center" rowspan="1" colspan="1">1907</td><td valign="top" align="center" rowspan="1" colspan="1">11.12</td><td valign="top" align="center" rowspan="1" colspan="1">21.97</td><td valign="top" align="center" rowspan="1" colspan="1">26.17</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Family-observed</td><td valign="top" align="center" rowspan="1" colspan="1">1250</td><td valign="top" align="center" rowspan="1" colspan="1">4.32</td><td valign="top" align="center" rowspan="1" colspan="1">12.24</td><td valign="top" align="center" rowspan="1" colspan="1">15.44</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">230</td><td valign="top" align="center" rowspan="1" colspan="1">5.22</td><td valign="top" align="center" rowspan="1" colspan="1">14.35</td><td valign="top" align="center" rowspan="1" colspan="1">15.65</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Previously treated</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">785</td><td valign="top" align="center" rowspan="1" colspan="1">8.54</td><td valign="top" align="center" rowspan="1" colspan="1">20.25</td><td valign="top" align="center" rowspan="1" colspan="1">25.48</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">3784</td><td valign="top" align="center" rowspan="1" colspan="1">7.24</td><td valign="top" align="center" rowspan="1" colspan="1">16.52</td><td valign="top" align="center" rowspan="1" colspan="1">19.98</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>MDR-tuberculosis</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">41</td><td valign="top" align="center" rowspan="1" colspan="1">12.20</td><td valign="top" align="center" rowspan="1" colspan="1">39.02</td><td valign="top" align="center" rowspan="1" colspan="1">41.46</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">1449</td><td valign="top" align="center" rowspan="1" colspan="1">6.69</td><td valign="top" align="center" rowspan="1" colspan="1">18.91</td><td valign="top" align="center" rowspan="1" colspan="1">24.15</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">3079</td><td valign="top" align="center" rowspan="1" colspan="1">7.76</td><td valign="top" align="center" rowspan="1" colspan="1">16.04</td><td valign="top" align="center" rowspan="1" colspan="1">19.13</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Sputum smear test</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">2341</td><td valign="top" align="center" rowspan="1" colspan="1">9.95</td><td valign="top" align="center" rowspan="1" colspan="1">21.87</td><td valign="top" align="center" rowspan="1" colspan="1">26.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">2089</td><td valign="top" align="center" rowspan="1" colspan="1">4.93</td><td valign="top" align="center" rowspan="1" colspan="1">12.40</td><td valign="top" align="center" rowspan="1" colspan="1">15.75</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">139</td><td valign="top" align="center" rowspan="1" colspan="1">3.60</td><td valign="top" align="center" rowspan="1" colspan="1">9.35</td><td valign="top" align="center" rowspan="1" colspan="1">12.95</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Cavitation</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">1235</td><td valign="top" align="center" rowspan="1" colspan="1">20.16</td><td valign="top" align="center" rowspan="1" colspan="1">44.78</td><td valign="top" align="center" rowspan="1" colspan="1">55.47</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">3277</td><td valign="top" align="center" rowspan="1" colspan="1">2.59</td><td valign="top" align="center" rowspan="1" colspan="1">6.53</td><td valign="top" align="center" rowspan="1" colspan="1">7.66</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">57</td><td valign="top" align="center" rowspan="1" colspan="1">12.28</td><td valign="top" align="center" rowspan="1" colspan="1">29.82</td><td valign="top" align="center" rowspan="1" colspan="1">35.09</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Comorbidity</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Diabetes</td><td valign="top" align="center" rowspan="1" colspan="1">473</td><td valign="top" align="center" rowspan="1" colspan="1">9.51</td><td valign="top" align="center" rowspan="1" colspan="1">21.99</td><td valign="top" align="center" rowspan="1" colspan="1">26.85</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">COPD</td><td valign="top" align="center" rowspan="1" colspan="1">22</td><td valign="top" align="center" rowspan="1" colspan="1">18.18</td><td valign="top" align="center" rowspan="1" colspan="1">45.45</td><td valign="top" align="center" rowspan="1" colspan="1">63.64</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hypertension</td><td valign="top" align="center" rowspan="1" colspan="1">67</td><td valign="top" align="center" rowspan="1" colspan="1">8.96</td><td valign="top" align="center" rowspan="1" colspan="1">29.85</td><td valign="top" align="center" rowspan="1" colspan="1">41.79</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chronic bronchitis</td><td valign="top" align="center" rowspan="1" colspan="1">87</td><td valign="top" align="center" rowspan="1" colspan="1">25.29</td><td valign="top" align="center" rowspan="1" colspan="1">44.83</td><td valign="top" align="center" rowspan="1" colspan="1">52.87</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cancer</td><td valign="top" align="center" rowspan="1" colspan="1">36</td><td valign="top" align="center" rowspan="1" colspan="1">36.11</td><td valign="top" align="center" rowspan="1" colspan="1">61.11</td><td valign="top" align="center" rowspan="1" colspan="1">69.44</td></tr></tbody></table><table-wrap-foot><p>COPD: chronic-obstructive pulmonary disease; MDR: multidrug-resistant.</p></table-wrap-foot></table-wrap><p><xref ref-type="table" rid="T3">Table&#x000a0;3</xref> shows the hazard ratios (HR) for deaths from all causes and from tuberculosis, with and without adjustment for age and sex. The adjusted HRs for deaths from all causes were 1.50 (95% CI: 0.91&#x02013;2.48) for participants with MDR-tuberculosis, 1.55 (95% CI: 1.35&#x02013;1.78) for smear-positive participants, and 1.26 (95% CI: 1.08&#x02013;1.49) for previously treated participants. The adjusted HRs for deaths from tuberculosis were 1.77 (95% CI: 0.62&#x02013;5.06) in participants with MDR-tuberculosis, 3.16 (95% CI: 2.06&#x02013;4.87) for smear-positive participants and 1.88 (95% CI: 1.24&#x02013;2.86) for previously treated participants. We also calculated the adjusted HRs for participants with diabetes (0.97; 95% CI: 0.80&#x02013;1.17), COPD (1.47; 95% CI: 0.86&#x02013;2.50), hypertension (1.43; 95% CI: 0.84&#x02013;2.46), chronic bronchitis (1.42; 95% CI: 1.05&#x02013;1.94) and cancer (1.93; 95% CI: 1.29&#x02013;2.90).</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Crude and adjusted hazard ratios for mortality in tuberculosis patients, Shanghai, China, 2004&#x02013;2014</title></caption><table frame="hsides" rules="groups"><col width="176" span="1"/><col width="49" span="1"/><col width="121" span="1"/><col width="11" span="1"/><col width="46" span="1"/><col width="138" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Subgroup</th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">HR (mortality from tuberculosis)<hr/></th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"/><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1">HR (mortality from all causes)<hr/></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Crude</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Adjusted (95% CI)<sup>a</sup></th><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Crude</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Adjusted (95% CI)<sup>a</sup></th></tr></thead><tbody><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Diagnosis</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Secondary pulmonary</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Primary pulmonary</td><td valign="top" align="center" rowspan="1" colspan="1">0.66</td><td valign="top" align="center" rowspan="1" colspan="1">1.42 (0.19&#x02013;10.39)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.28</td><td valign="top" align="center" rowspan="1" colspan="1">0.68 (0.22&#x02013;2.13)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Disseminated pulmonary</td><td valign="top" align="center" rowspan="1" colspan="1">2.31</td><td valign="top" align="center" rowspan="1" colspan="1">1.86 (0.26&#x02013;13.51)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">3.38</td><td valign="top" align="center" rowspan="1" colspan="1">2.10 (1.04&#x02013;4.24)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Extra-pulmonary</td><td valign="top" align="center" rowspan="1" colspan="1">0.72</td><td valign="top" align="center" rowspan="1" colspan="1">0.68 (0.33&#x02013;1.40)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.84</td><td valign="top" align="center" rowspan="1" colspan="1">0.81 (0.63&#x02013;1.05)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Other</td><td valign="top" align="center" rowspan="1" colspan="1">1.58</td><td valign="top" align="center" rowspan="1" colspan="1">1.46 (0.20&#x02013;10.65)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.69</td><td valign="top" align="center" rowspan="1" colspan="1">0.85 (0.32&#x02013;2.29)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Clinical management</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Directly-observed</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Self-administered</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.57</td><td valign="top" align="center" rowspan="1" colspan="1">1.22 (0.45&#x02013;3.34)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hospital</td><td valign="top" align="center" rowspan="1" colspan="1">1.80</td><td valign="top" align="center" rowspan="1" colspan="1">2.09 (1.18&#x02013;3.73)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.43</td><td valign="top" align="center" rowspan="1" colspan="1">1.39 (1.14&#x02013;1.69)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Family-observed</td><td valign="top" align="center" rowspan="1" colspan="1">0.64</td><td valign="top" align="center" rowspan="1" colspan="1">0.97 (0.47&#x02013;1.98)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.79</td><td valign="top" align="center" rowspan="1" colspan="1">0.99 (0.79&#x02013;1.25)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">1.70</td><td valign="top" align="center" rowspan="1" colspan="1">1.76 (0.64&#x02013;4.87)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.87</td><td valign="top" align="center" rowspan="1" colspan="1">0.88 (0.57&#x02013;1.35)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Previously treated</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">1.67</td><td valign="top" align="center" rowspan="1" colspan="1">1.88 (1.24&#x02013;2.86)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.31</td><td valign="top" align="center" rowspan="1" colspan="1">1.26 (1.08&#x02013;1.49)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>MDR-tuberculosis</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">2.79</td><td valign="top" align="center" rowspan="1" colspan="1">1.77 (0.62&#x02013;5.06)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">2.12</td><td valign="top" align="center" rowspan="1" colspan="1">1.50 (0.91&#x02013;2.48)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">0.65</td><td valign="top" align="center" rowspan="1" colspan="1">0.72 (0.48&#x02013;1.08)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.81</td><td valign="top" align="center" rowspan="1" colspan="1">0.95 (0.82&#x02013;1.11)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Sputum smear test</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">4.33</td><td valign="top" align="center" rowspan="1" colspan="1">3.16 (2.06&#x02013;4.87)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">2.31</td><td valign="top" align="center" rowspan="1" colspan="1">1.55 (1.35&#x02013;1.78)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">1.21</td><td valign="top" align="center" rowspan="1" colspan="1">1.34 (0.32&#x02013;5.67)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.93</td><td valign="top" align="center" rowspan="1" colspan="1">0.97 (0.60&#x02013;1.56)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Cavitation</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">1.28</td><td valign="top" align="center" rowspan="1" colspan="1">1.32 (0.91&#x02013;1.93)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.99</td><td valign="top" align="center" rowspan="1" colspan="1">1.04 (0.90&#x02013;1.20)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.00</td><td valign="top" align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Unknown</td><td valign="top" align="center" rowspan="1" colspan="1">2.74</td><td valign="top" align="center" rowspan="1" colspan="1">2.69 (0.97&#x02013;7.45)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.84</td><td valign="top" align="center" rowspan="1" colspan="1">1.59 (1.02&#x02013;2.49)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Comorbidity</bold></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Diabetes</td><td valign="top" align="center" rowspan="1" colspan="1">1.09</td><td valign="top" align="center" rowspan="1" colspan="1">0.85 (0.49&#x02013;1.46)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">1.40</td><td valign="top" align="center" rowspan="1" colspan="1">0.97 (0.80&#x02013;1.17)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">COPD</td><td valign="top" align="center" rowspan="1" colspan="1">1.58</td><td valign="top" align="center" rowspan="1" colspan="1">0.88 (0.12&#x02013;6.37)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">4.05</td><td valign="top" align="center" rowspan="1" colspan="1">1.47 (0.86&#x02013;2.50)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Hypertension</td><td valign="top" align="center" rowspan="1" colspan="1">0.50</td><td valign="top" align="center" rowspan="1" colspan="1">0.28 (0.04&#x02013;2.03)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">5.29</td><td valign="top" align="center" rowspan="1" colspan="1">1.43 (0.84&#x02013;2.46)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chronic bronchitis</td><td valign="top" align="center" rowspan="1" colspan="1">3.00</td><td valign="top" align="center" rowspan="1" colspan="1">2.03 (0.91&#x02013;4.54)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">3.33</td><td valign="top" align="center" rowspan="1" colspan="1">1.42 (1.05&#x02013;1.94)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Cancer</td><td valign="top" align="center" rowspan="1" colspan="1">1.96</td><td valign="top" align="center" rowspan="1" colspan="1">1.26 (0.31&#x02013;5.16)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">5.10</td><td valign="top" align="center" rowspan="1" colspan="1">1.93 (1.29&#x02013;2.90)</td></tr></tbody></table><table-wrap-foot><p>CI: confidence interval; COPD: chronic obstructive pulmonary disease; HR: hazard ratios; MDR: multidrug resistant.</p><p><sup>a</sup> Based on Cox regression models, adjusted for age and sex.</p></table-wrap-foot></table-wrap><p>The cumulative survival curves (<xref ref-type="fig" rid="F1">Fig.&#x000a0;1</xref>) show that the highest risk of death was in the first year, especially during the 2-month intensive treatment phase. After the treatment period, survival improved, especially when considering deaths from tuberculosis only.</p><fig id="F1" fig-type="figure" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Survival curves for study participants, Shanghai, China, 2004&#x02013;2014</p></caption><graphic xlink:href="BLT.15.154161-F1"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>The risk of death in the study population was five times that in the general population of China (SMR 5.2). This is lower than previously reported for people with tuberculosis in India (6.1),<xref rid="R17" ref-type="bibr"><sup>17</sup></xref> the Netherlands (8.3),<xref rid="R18" ref-type="bibr"><sup>18</sup></xref> and Ethiopia (10.0),<xref rid="R19" ref-type="bibr"><sup>19</sup></xref> at least in part because there is less co-infection with HIV in China.<xref rid="R20" ref-type="bibr"><sup>20</sup></xref> Men had higher mortality rates than women, which may be because of sex differences in clinical characteristics (smear results, cavitation, prevalence of comorbidities and MDR-tuberculosis),<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> a higher likelihood of noncompliance with treatment, or the presence of additional risk factors such as smoking.<xref rid="R6" ref-type="bibr"><sup>6</sup></xref><sup>,</sup><xref rid="R17" ref-type="bibr"><sup>17</sup></xref><sup>,</sup><xref rid="R19" ref-type="bibr"><sup>19</sup></xref><sup>,</sup><xref rid="R22" ref-type="bibr"><sup>22</sup></xref> Participants with disseminated pulmonary disease, smear-positive disease or MDR-tuberculosis had higher SMRs than those without these characteristics. This is as expected, given that all of these characteristics are related to disease severity.</p><p>Among our participants, 25% were undergoing directly observed treatment, short-course (DOTS) facilitated by health-care workers. Contrary to the general expectation that DOTS will substantially increase the effectiveness of treatment for tuberculosis,<xref rid="R23" ref-type="bibr"><sup>23</sup></xref><sup>,</sup><xref rid="R24" ref-type="bibr"><sup>24</sup></xref> we found that participants receiving DOTS facilitated by health-care workers had a higher cumulative case-fatality rate than those under self-administered and family-observed management. This may be because people who were willing to remain under DOTS were in poorer health than those under self-administered and family-observed management. Consistent with our findings for Shanghai, studies in Ethiopia,<xref rid="R25" ref-type="bibr"><sup>25</sup></xref> India<xref rid="R26" ref-type="bibr"><sup>26</sup></xref> and the United Republic of Tanzania<xref rid="R27" ref-type="bibr"><sup>27</sup></xref> also reported good treatment outcomes following self-administered tuberculosis treatment. However, contrary results have been obtained in other settings. For example, a study of health-community workers found that DOTS was more beneficial than family-observed management,<xref rid="R28" ref-type="bibr"><sup>28</sup></xref> and a randomized trial in Nepal indicated that family-observed management produced similar outcomes as health-community worker facilitated DOTS.<xref rid="R29" ref-type="bibr"><sup>29</sup></xref> Hospitalized people with tuberculosis in China typically have severe disease, which is consistent with this group having the highest cumulative case-fatality rate in our cohort.<xref rid="R30" ref-type="bibr"><sup>30</sup></xref></p><p>Mortality was highest in the first year, and then declined substantially with time in almost all of the analysed subgroups. During the 10&#x000a0;year follow-up, about one third of the deaths occurred in the first year, and 80% of the deaths occurred within five years of diagnosis. Tuberculosis-related mortality continued to occur even after the completion of treatment. This emphasizes that the definition of tuberculosis mortality should not be restricted to the treatment period alone, because this may lead to an underestimation of tuberculosis-related mortality.</p><p>Previous studies have identified several co-morbidities that are risk factors for all-cause mortality during tuberculosis treatment, including renal failure, respiratory disease, cardiovascular disease, cancer, COPD and diabetes.<xref rid="R31" ref-type="bibr"><sup>31</sup></xref><sup>&#x02013;</sup><xref rid="R33" ref-type="bibr"><sup>33</sup></xref> Our analysis identified several such comorbidities. In univariate analyses, people with tuberculosis with diabetes, COPD, chronic bronchitis, hypertension and cancer also had increased mortality. However, after adjusting for age and sex, only chronic bronchitis and cancer were significantly associated with death from all causes. The impact of chronic bronchitis on all-cause mortality is consistent with our previous report.<xref rid="R15" ref-type="bibr"><sup>15</sup></xref> It is possible that damage from chronic bronchitis may exacerbate some of the symptoms of tuberculosis, as both conditions are associated with chronic airflow obstruction and other respiratory symptoms.<xref rid="R34" ref-type="bibr"><sup>34</sup></xref></p><p>Our study has several limitations. First, we did not ascertain the HIV status of participants because HIV testing is not compulsory for people with tuberculosis in China. However, previous screening studies reported that the HIV prevalence among people with tuberculosis in China was low.<xref rid="R9" ref-type="bibr"><sup>9</sup></xref><sup>,</sup><xref rid="R10" ref-type="bibr"><sup>10</sup></xref> Second, we determined the cause of death using the death certificate database. In Shanghai, a death registration system was established based on ICD-10 for defining the causes of death. Thus, there may have been misclassification of tuberculosis deaths, although misclassification bias would have been reduced by our policy of confirming cause of death during follow-up. Participants who self-administered treatment were possibly marked as being under DOTS in the tuberculosis management system,<xref rid="R35" ref-type="bibr"><sup>35</sup></xref> which may have introduced a bias. Loss to follow-up during or after treatment may have led to an overestimation of mortality rates, since recording of deaths from the death registration database is nearly complete. Finally, although geographic characteristics and tuberculosis prevalence were considered in selecting the study districts, the selected districts may not have provided a representative sample of the population of Shanghai.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>In this cohort of people with tuberculosis in Shanghai, mortality was higher during treatment, suggesting the importance of improving clinical management and treatment for tuberculosis. Interventions during treatment (i.e. monitoring and managing the side-effects of anti-tuberculosis medication) may reduce the rate of tuberculosis deaths while follow-up can lead to reduced deaths from other causes. Timely detection and management of comorbidities among people with tuberculosis is necessary to prevent deaths during treatment for tuberculosis, as reported by other studies.<xref rid="R36" ref-type="bibr"><sup>36</sup></xref> People with tuberculosis and major comorbidities such as chronic bronchitis and lung cancer need careful management. When appropriate, follow-up and assessment coordinated by tuberculosis departments may improve the management of these conditions. Post-treatment mortality could be used as additional evidence of case fatality (obtained through routine reports) to better characterize overall mortality in people with tuberculosis.</p></sec></body><back><fn-group><title>Funding:</title><fn fn-type="supported-by"><p>Funding for this research was provided by the National Key Scientific and Technological Project Against Major Infectious Diseases (2013ZX10004903-005).</p></fn></fn-group><fn-group><title>Competing interests:</title><fn fn-type="financial-disclosure"><p>None declared.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><string-name><surname>Parwati</surname>
<given-names>I</given-names></string-name>, <string-name><surname>van Crevel</surname>
<given-names>R</given-names></string-name>, <string-name><surname>van Soolingen</surname>
<given-names>D</given-names></string-name>. <article-title>Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains.</article-title>
<source>Lancet Infect Dis</source>. <year>2010</year>
<month>2</month>;<volume>10</volume>(<issue>2</issue>):<fpage>103</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(09)70330-5</pub-id><pub-id pub-id-type="pmid">20113979</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="book">Global tuberculosis report 2013. Geneva: Global Tuberculosis Programme, World Health Organization; 2013. pp. 6&#x02013;27. Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf">http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf</ext-link> [cited 2015 Sep 11].</mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Ruan</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Chin</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Xia</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal>
<article-title>Tuberculosis prevalence in China, 1990&#x02013;2010; a longitudinal analysis of national survey data.</article-title>
<source>Lancet</source>. <year>2014</year>
<month>6</month>
<day>14</day>;<volume>383</volume>(<issue>9934</issue>):<fpage>2057</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(13)62639-2</pub-id><pub-id pub-id-type="pmid">24650955</pub-id></mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="journal"><string-name><surname>Cullinan</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Meredith</surname>
<given-names>SK</given-names></string-name>. <article-title>Deaths in adults with notified pulmonary tuberculosis 1983&#x02013;5.</article-title>
<source>Thorax</source>. <year>1991</year>
<month>5</month>;<volume>46</volume>(<issue>5</issue>):<fpage>347</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1136/thx.46.5.347</pub-id><pub-id pub-id-type="pmid">2068691</pub-id></mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="journal"><string-name><surname>Zhao</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Chin</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>G</given-names></string-name>, <etal>et al.</etal>
<article-title>National survey of drug-resistant tuberculosis in China.</article-title>
<source>N Engl J Med</source>. <year>2012</year>
<month>6</month>
<day>7</day>;<volume>366</volume>(<issue>23</issue>):<fpage>2161</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1108789</pub-id><pub-id pub-id-type="pmid">22670902</pub-id></mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="journal"><string-name><surname>Shen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Deriemer</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Yuan</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Xia</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Gui</surname>
<given-names>X</given-names></string-name>, <etal>et al.</etal>
<article-title>Deaths among tuberculosis cases in Shanghai, China: who is at risk?</article-title>
<source>BMC Infect Dis</source>. <year>2009</year>;<volume>9</volume>(<issue>1</issue>):<fpage>95</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2334-9-95</pub-id><pub-id pub-id-type="pmid">19531267</pub-id></mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="journal"><article-title>The office of the fifth national TB epidemiological survey. Report on nationwide random survey for the epidemiology of tuberculosis in 2010.</article-title>
<source>Journal of Chinese Anti-Tuberculosis Association.</source>
<year>2012</year>;<volume>34</volume>(<issue>8</issue>):<fpage>485</fpage>&#x02013;<lpage>508</lpage>.</mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="web">International statistical classification of diseases and related health problems. 10th revision, edition 2010. Geneva: World Health Organization; 2010. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf?ua=1">http://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf?ua=1</ext-link> [cited 2015 Sep 25].</mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><string-name><surname>Xu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mahapatra</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lai</surname>
<given-names>Y</given-names></string-name>, <etal>et al.</etal>
<article-title>Prevalence and predictors of HIV among Chinese tuberculosis patients by provider-initiated HIV testing and counselling (PITC): a multisite study in South Central of China.</article-title>
<source>PLoS ONE</source>. <year>2014</year>;<volume>9</volume>(<issue>2</issue>):<fpage>e89723</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0089723</pub-id><pub-id pub-id-type="pmid">24586987</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Graviss</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>X</given-names></string-name>. <article-title>HIV infection among TB and non-TB patients in China, 2009&#x02013;2012.</article-title>
<source>J Infect</source>. <year>2014</year>
<month>4</month>;<volume>68</volume>(<issue>4</issue>):<fpage>399</fpage>&#x02013;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2013.12.015</pub-id><pub-id pub-id-type="pmid">24412569</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><string-name><surname>Straetemans</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Glaziou</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Bierrenbach</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Sismanidis</surname>
<given-names>C</given-names></string-name>, <string-name><surname>van der Werf</surname>
<given-names>MJ</given-names></string-name>. <article-title>Assessing tuberculosis case fatality ratio: a meta-analysis.</article-title>
<source>PLoS ONE</source>. <year>2011</year>;<volume>6</volume>(<issue>6</issue>):<fpage>e20755</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0020755</pub-id><pub-id pub-id-type="pmid">21738585</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="journal"><article-title>An expanded DOTS framework for effective tuberculosis control.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2002</year>
<month>5</month>;<volume>6</volume>(<issue>5</issue>):<fpage>378</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="pmid">12019913</pub-id></mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><string-name><surname>Lin</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Kuo</surname>
<given-names>YW</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>JY</given-names></string-name>, <string-name><surname>Hsu</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>JM</given-names></string-name>, <etal>et al.</etal>
<article-title>Tuberculosis mortality: patient characteristics and causes.</article-title>
<source>BMC Infect Dis</source>. <year>2014</year>;<volume>14</volume>(<issue>1</issue>):<fpage>5</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2334-14-5</pub-id><pub-id pub-id-type="pmid">24387757</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="journal"><string-name><surname>Walpola</surname>
<given-names>HC</given-names></string-name>, <string-name><surname>Siskind</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Patel</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Konstantinos</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Derhy</surname>
<given-names>P</given-names></string-name>. <article-title>Tuberculosis-related deaths in Queensland, Australia, 1989&#x02013;1998: characteristics and risk factors.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2003</year>
<month>8</month>;<volume>7</volume>(<issue>8</issue>):<fpage>742</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">12921150</pub-id></mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname>
<given-names>WB</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Yuan</surname>
<given-names>ZA</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>WL</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>B</given-names></string-name>. <article-title>Deaths of tuberculosis patients in urban China: a retrospective cohort study.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2013</year>
<month>4</month>;<volume>17</volume>(<issue>4</issue>):<fpage>493</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.5588/ijtld.12.0400</pub-id><pub-id pub-id-type="pmid">23433006</pub-id></mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="web">China health statistical yearbook 2013. Laiyun: China Statistics Press; 2013. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.stats.gov.cn/tjsj/ndsj/2013/indexeh.htm">http://www.stats.gov.cn/tjsj/ndsj/2013/indexeh.htm</ext-link><ext-link ext-link-type="uri" xlink:href="http://"/>[cited 2015 Sep 25].</mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="journal"><string-name><surname>Kolappan</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Subramani</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Karunakaran</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Narayanan</surname>
<given-names>PR</given-names></string-name>. <article-title>Mortality of tuberculosis patients in Chennai, India.</article-title>
<source>Bull World Health Organ</source>. <year>2006</year>
<month>7</month>;<volume>84</volume>(<issue>7</issue>):<fpage>555</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.98.11040816</pub-id><pub-id pub-id-type="pmid">16878229</pub-id></mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="journal"><string-name><surname>Borgdorff</surname>
<given-names>MW</given-names></string-name>, <string-name><surname>Veen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Kalisvaart</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Nagelkerke</surname>
<given-names>N</given-names></string-name>. <article-title>Mortality among tuberculosis patients in The Netherlands in the period 1993&#x02013;1995.</article-title>
<source>Eur Respir J</source>. <year>1998</year>
<month>4</month>;<volume>11</volume>(<issue>4</issue>):<fpage>816</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.2471/BLT.05.022087</pub-id><pub-id pub-id-type="pmid">9623682</pub-id></mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="journal"><string-name><surname>Datiko</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Lindtj&#x000f8;rn</surname>
<given-names>B</given-names></string-name>. <article-title>Mortality in successfully treated tuberculosis patients in southern Ethiopia: retrospective follow-up study.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2010</year>
<month>7</month>;<volume>14</volume>(<issue>7</issue>):<fpage>866</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">20550770</pub-id></mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="journal"><string-name><surname>Mi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Du</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Yue</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Harries</surname>
<given-names>AD</given-names></string-name>, <etal>et al.</etal>
<article-title>Is resistance to anti-tuberculosis drugs associated with type 2 diabetes mellitus? A register review in Beijing, China.</article-title>
<source>Glob Health Action</source>. <year>2014</year>;<volume>7</volume>(<issue>0</issue>):<fpage>24022</fpage>. <pub-id pub-id-type="doi">10.3402/gha.v7.24022</pub-id><pub-id pub-id-type="pmid">24845213</pub-id></mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="journal"><string-name><surname>Liew</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Khoo</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Ho</surname>
<given-names>BK</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>YK</given-names></string-name>, <string-name><surname>Mimi</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Fazlina</surname>
<given-names>MY</given-names></string-name>, <etal>et al.</etal>
<article-title>Tuberculosis in Malaysia: predictors of treatment outcomes in a national registry.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2015</year>
<month>7</month>;<volume>19</volume>(<issue>7</issue>):<fpage>764</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.5588/ijtld.14.0767</pub-id><pub-id pub-id-type="pmid">26056099</pub-id></mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="journal"><string-name><surname>Lefebvre</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Falzon</surname>
<given-names>D</given-names></string-name>. <article-title>Risk factors for death among tuberculosis cases: analysis of European surveillance data.</article-title>
<source>Eur Respir J</source>. <year>2008</year>
<month>6</month>;<volume>31</volume>(<issue>6</issue>):<fpage>1256</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.00131107</pub-id><pub-id pub-id-type="pmid">18515556</pub-id></mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="journal"><string-name><surname>Anuwatnonthakate</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Limsomboon</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Nateniyom</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wattanaamornkiat</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Komsakorn</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Moolphate</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal>
<article-title>Directly observed therapy and improved tuberculosis treatment outcomes in Thailand.</article-title>
<source>PLoS ONE</source>. <year>2008</year>;<volume>3</volume>(<issue>8</issue>):<fpage>e3089</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0003089</pub-id><pub-id pub-id-type="pmid">18769479</pub-id></mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="journal"><string-name><surname>Bloss</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Chan</surname>
<given-names>PC</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>NW</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>KF</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Cegielski</surname>
<given-names>P</given-names></string-name>. <article-title>Increasing directly observed therapy related to improved tuberculosis treatment outcomes in Taiwan.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2012</year>
<month>4</month>;<volume>16</volume>(<issue>4</issue>):<fpage>462</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.5588/ijtld.11.0121</pub-id><pub-id pub-id-type="pmid">22640512</pub-id></mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="journal"><string-name><surname>Khogali</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Zachariah</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Reid</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Alipon</surname>
<given-names>SC</given-names></string-name>, <string-name><surname>Zimble</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mahama</surname>
<given-names>G</given-names></string-name>, <etal>et al.</etal>
<article-title>Self-administered treatment for tuberculosis among pastoralists in rural Ethiopia: how well does it work?</article-title>
<source>Int Health</source>. <year>2014</year>
<month>6</month>;<volume>6</volume>(<issue>2</issue>):<fpage>112</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/inthealth/ihu008</pub-id><pub-id pub-id-type="pmid">24639343</pub-id></mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><string-name><surname>Das</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Isaakidis</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Armstrong</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Gundipudi</surname>
<given-names>NR</given-names></string-name>, <string-name><surname>Babu</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Qureshi</surname>
<given-names>IA</given-names></string-name>, <etal>et al.</etal>
<article-title>Directly-observed and self-administered tuberculosis treatment in a chronic, low-intensity conflict setting in India.</article-title>
<source>PLoS ONE</source>. <year>2014</year>;<volume>9</volume>(<issue>3</issue>):<fpage>e92131</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0092131</pub-id><pub-id pub-id-type="pmid">24651176</pub-id></mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="journal"><string-name><surname>van den Boogaard</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lyimo</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Irongo</surname>
<given-names>CF</given-names></string-name>, <string-name><surname>Boeree</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Schaalma</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Aarnoutse</surname>
<given-names>RE</given-names></string-name>, <etal>et al.</etal>
<article-title>Community vs. facility-based directly observed treatment for tuberculosis in Tanzania&#x02019;s Kilimanjaro region.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2009</year>
<month>12</month>;<volume>13</volume>(<issue>12</issue>):<fpage>1524</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">19919771</pub-id></mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="journal"><string-name><surname>Pungrassami</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Johnsen</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Chongsuvivatwong</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Olsen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>S&#x000f8;rensen</surname>
<given-names>HT</given-names></string-name>. <article-title>Practice of directly observed treatment (DOT) for tuberculosis in southern Thailand: comparison between different types of DOT observers.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2002</year>
<month>5</month>;<volume>6</volume>(<issue>5</issue>):<fpage>389</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="pmid">12019914</pub-id></mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="journal"><string-name><surname>Newell</surname>
<given-names>JN</given-names></string-name>, <string-name><surname>Baral</surname>
<given-names>SC</given-names></string-name>, <string-name><surname>Pande</surname>
<given-names>SB</given-names></string-name>, <string-name><surname>Bam</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Malla</surname>
<given-names>P</given-names></string-name>. <article-title>Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial.</article-title>
<source>Lancet</source>. <year>2006</year>
<month>3</month>
<day>18</day>;<volume>367</volume>(<issue>9514</issue>):<fpage>903</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(06)68380-3</pub-id><pub-id pub-id-type="pmid">16546538</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="journal"><string-name><surname>Lui</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Wong</surname>
<given-names>RY</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Lai</surname>
<given-names>RW</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>TC</given-names></string-name>, <etal>et al.</etal>
<article-title>High mortality in adults hospitalized for active tuberculosis in a low HIV prevalence setting.</article-title>
<source>PLoS ONE</source>. <year>2014</year>;<volume>9</volume>(<issue>3</issue>):<fpage>e92077</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0092077</pub-id><pub-id pub-id-type="pmid">24642794</pub-id></mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="journal"><string-name><surname>Erbes</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Oettel</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Raffenberg</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mauch</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Schmidt-Ioanas</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lode</surname>
<given-names>H</given-names></string-name>. <article-title>Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care.</article-title>
<source>Eur Respir J</source>. <year>2006</year>
<month>6</month>;<volume>27</volume>(<issue>6</issue>):<fpage>1223</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.06.00088105</pub-id><pub-id pub-id-type="pmid">16481385</pub-id></mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><string-name><surname>Mathew</surname>
<given-names>TA</given-names></string-name>, <string-name><surname>Ovsyanikova</surname>
<given-names>TN</given-names></string-name>, <string-name><surname>Shin</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Gelmanova</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Balbuena</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Atwood</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal>
<article-title>Causes of death during tuberculosis treatment in Tomsk Oblast, Russia.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2006</year>
<month>8</month>;<volume>10</volume>(<issue>8</issue>):<fpage>857</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">16898369</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><string-name><surname>Chiang</surname>
<given-names>CY</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Enarson</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>TP</given-names></string-name>, <string-name><surname>Luh</surname>
<given-names>KT</given-names></string-name>. <article-title>Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2009</year>
<month>1</month>;<volume>13</volume>(<issue>1</issue>):<fpage>105</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">19105887</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal"><string-name><surname>Ehrlich</surname>
<given-names>RI</given-names></string-name>, <string-name><surname>Adams</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Baatjies</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Jeebhay</surname>
<given-names>MF</given-names></string-name>. <article-title>Chronic airflow obstruction and respiratory symptoms following tuberculosis: a review of South African studies.</article-title>
<source>Int J Tuberc Lung Dis</source>. <year>2011</year>
<month>7</month>;<volume>15</volume>(<issue>7</issue>):<fpage>886</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.5588/ijtld.10.0526</pub-id><pub-id pub-id-type="pmid">21477424</pub-id></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><string-name><surname>Wei</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Walley</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Liang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>R</given-names></string-name>. <article-title>Adapting a generic tuberculosis control operational guideline and scaling it up in China: a qualitative case study.</article-title>
<source>BMC Public Health</source>. <year>2008</year>;<volume>8</volume>(<issue>1</issue>):<fpage>260</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2458-8-260</pub-id><pub-id pub-id-type="pmid">18662410</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><string-name><surname>Borgdorff</surname>
<given-names>MW</given-names></string-name>, <string-name><surname>Floyd</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Broekmans</surname>
<given-names>JF</given-names></string-name>. <article-title>Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries.</article-title>
<source>Bull World Health Organ</source>. <year>2002</year>;<volume>80</volume>(<issue>3</issue>):<fpage>217</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">11984608</pub-id></mixed-citation></ref></ref-list></back></article>